| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.812 | 0.004 | 0.904 | Spasmolytic | 0.749 0.005 DBMET00315 0.484 0.025 DBMET00844 0.843 0.004 DBMET00873 0.656 0.009 DBMET00834 0.79 0.004 DBMET00872 0.732 0.005 DBMET00845 0.904 0.003 DBMET00881 0.79 0.004 DBMET00874 0.904 0.003 DBMET00879 | DBMET00879 | |
| 0.712 | 0.004 | 0.873 | Histamine release inhibitor | 0.37 0.09 DBMET00531 0.632 0.008 DBMET00315 0.501 0.028 DBMET00844 0.774 0.004 DBMET00873 0.695 0.005 DBMET00834 0.701 0.005 DBMET00872 0.733 0.004 DBMET00845 0.873 0.003 DBMET00881 0.701 0.005 DBMET00874 0.873 0.003 DBMET00879 | DBMET00879 | |
| 0.634 | 0.003 | 0.634 | 5 Hydroxytryptamine 1F antagonist | 0.558 0.004 DBMET00315 0.298 0.005 DBMET00844 0.547 0.004 DBMET00873 0.484 0.004 DBMET00834 0.382 0.005 DBMET00872 0.096 0.033 DBMET00881 0.382 0.005 DBMET00874 0.096 0.033 DBMET00879 | ||
| 0.589 | 0.006 | 0.623 | Psychostimulant | 0.623 0.005 DBMET00315 0.289 0.046 DBMET00844 0.56 0.007 DBMET00873 0.516 0.009 DBMET00834 0.589 0.006 DBMET00872 0.438 0.017 DBMET00845 0.57 0.007 DBMET00881 0.589 0.006 DBMET00874 0.57 0.007 DBMET00879 | DBMET00315 | |
| 0.566 | 0.004 | 0.879 | Mediator release inhibitor | 0.497 0.004 DBMET00315 0.153 0.027 DBMET00844 0.626 0.004 DBMET00873 0.543 0.004 DBMET00834 0.56 0.004 DBMET00872 0.422 0.005 DBMET00845 0.879 0.002 DBMET00881 0.56 0.004 DBMET00874 0.879 0.002 DBMET00879 | DBMET00879 | |
| 0.57 | 0.01 | 0.601 | HERG channel blocker | 0.414 0.025 DBMET00315 0.601 0.008 DBMET00844 0.319 0.044 DBMET00873 0.378 0.032 DBMET00834 0.201 0.09 DBMET00872 0.201 0.09 DBMET00874 | DBMET00844 | |
| 0.521 | 0.007 | 0.521 | P-glycoprotein inhibitor | 0.473 0.01 DBMET00315 0.295 0.03 DBMET00844 0.477 0.01 DBMET00873 0.438 0.013 DBMET00834 0.429 0.013 DBMET00872 0.268 0.036 DBMET00845 0.376 0.019 DBMET00881 0.429 0.013 DBMET00874 0.376 0.019 DBMET00879 | ||
| 0.523 | 0.013 | 0.538 | Potassium channel (Voltage-sensitive) blocker | 0.391 0.028 DBMET00315 0.538 0.011 DBMET00844 0.292 0.052 DBMET00873 0.33 0.041 DBMET00834 0.199 0.096 DBMET00872 0.199 0.096 DBMET00874 | DBMET00844 | |
| 0.544 | 0.038 | 0.644 | Analgesic | 0.644 0.02 DBMET00315 0.607 0.026 DBMET00844 0.474 0.057 DBMET00873 0.486 0.053 DBMET00834 0.573 0.032 DBMET00872 0.573 0.032 DBMET00874 | DBMET00315 | |
| 0.502 | 0.011 | 0.502 | Potassium channel blocker | 0.377 0.027 DBMET00315 0.427 0.018 DBMET00844 0.29 0.05 DBMET00873 0.307 0.044 DBMET00834 0.182 0.105 DBMET00872 0.182 0.105 DBMET00874 | ||
| 0.492 | 0.004 | 0.492 | Histamine H1 receptor antagonist | 0.354 0.005 DBMET00315 0.155 0.023 DBMET00844 0.316 0.006 DBMET00873 0.246 0.01 DBMET00834 0.215 0.013 DBMET00872 0.102 0.04 DBMET00881 0.215 0.013 DBMET00874 0.102 0.04 DBMET00879 | ||
| 0.552 | 0.068 | 0.786 | Antiinflammatory | 0.54 0.072 DBMET00315 0.376 0.154 DBMET00844 0.567 0.063 DBMET00873 0.603 0.053 DBMET00834 0.556 0.066 DBMET00872 0.776 0.019 DBMET00845 0.786 0.017 DBMET00881 0.556 0.066 DBMET00874 0.786 0.017 DBMET00879 | DBMET00879 | |
| 0.485 | 0.002 | 0.485 | Sphingomyelinase inhibitor | 0.113 0.047 DBMET00531 0.451 0.002 DBMET00315 0.224 0.006 DBMET00844 0.409 0.003 DBMET00873 0.313 0.003 DBMET00834 0.365 0.003 DBMET00872 0.245 0.005 DBMET00845 0.367 0.003 DBMET00881 0.365 0.003 DBMET00874 0.367 0.003 DBMET00879 | ||
| 0.466 | 0.004 | 0.466 | Alpha 2c adrenoreceptor antagonist | 0.457 0.004 DBMET00315 0.209 0.016 DBMET00844 0.429 0.004 DBMET00873 0.286 0.007 DBMET00834 0.421 0.004 DBMET00872 0.109 0.058 DBMET00881 0.421 0.004 DBMET00874 0.109 0.058 DBMET00879 | ||
| 0.466 | 0.004 | 0.468 | Alpha 2b adrenoreceptor antagonist | 0.468 0.004 DBMET00315 0.205 0.022 DBMET00844 0.419 0.005 DBMET00873 0.281 0.011 DBMET00834 0.421 0.005 DBMET00872 0.421 0.005 DBMET00874 | DBMET00315 | |
| 0.464 | 0.015 | 0.464 | Anticonvulsant | 0.396 0.022 DBMET00315 0.272 0.049 DBMET00873 0.436 0.018 DBMET00834 0.223 0.069 DBMET00872 0.223 0.069 DBMET00874 | ||
| 0.412 | 0.005 | 0.412 | Antihistaminic | 0.327 0.009 DBMET00315 0.082 0.074 DBMET00844 0.2 0.021 DBMET00873 0.184 0.024 DBMET00834 0.155 0.031 DBMET00872 0.155 0.031 DBMET00874 | ||
| 0.403 | 0.005 | 0.403 | Histamine antagonist | 0.317 0.009 DBMET00315 0.181 0.022 DBMET00873 0.173 0.024 DBMET00834 0.138 0.033 DBMET00872 0.138 0.033 DBMET00874 | ||
| 0.385 | 0.003 | 0.385 | 5 Hydroxytryptamine 5A antagonist | 0.262 0.004 DBMET00315 0.069 0.032 DBMET00844 0.274 0.004 DBMET00873 0.19 0.005 DBMET00834 0.203 0.005 DBMET00872 0.203 0.005 DBMET00874 | ||
| 0.375 | 0.005 | 0.5 | 5 Hydroxytryptamine uptake inhibitor | 0.466 0.004 DBMET00315 0.5 0.004 DBMET00844 0.23 0.009 DBMET00873 0.217 0.01 DBMET00834 0.317 0.005 DBMET00872 0.317 0.005 DBMET00874 | DBMET00844 | |
| 0.375 | 0.005 | 0.375 | Alpha 2a adrenoreceptor antagonist | 0.365 0.005 DBMET00315 0.114 0.031 DBMET00844 0.366 0.005 DBMET00873 0.23 0.011 DBMET00834 0.355 0.005 DBMET00872 0.355 0.005 DBMET00874 | ||
| 0.372 | 0.005 | 0.372 | Alpha 2 adrenoreceptor antagonist | 0.36 0.005 DBMET00315 0.11 0.041 DBMET00844 0.33 0.007 DBMET00873 0.224 0.014 DBMET00834 0.32 0.007 DBMET00872 0.32 0.007 DBMET00874 | ||
| 0.398 | 0.036 | 0.601 | Vasodilator, coronary | 0.249 0.136 DBMET00531 0.362 0.05 DBMET00315 0.199 0.183 DBMET00844 0.397 0.036 DBMET00873 0.31 0.08 DBMET00834 0.36 0.05 DBMET00872 0.412 0.031 DBMET00845 0.601 0.008 DBMET00881 0.36 0.05 DBMET00874 0.601 0.008 DBMET00879 | DBMET00879 | |
| 0.359 | 0.004 | 0.359 | 5 Hydroxytryptamine 5 antagonist | 0.261 0.004 DBMET00315 0.061 0.035 DBMET00844 0.254 0.004 DBMET00873 0.184 0.005 DBMET00834 0.195 0.005 DBMET00872 0.195 0.005 DBMET00874 | ||
| 0.358 | 0.022 | 0.371 | Anesthetic general | 0.227 0.061 DBMET00531 0.258 0.047 DBMET00315 0.371 0.02 DBMET00873 0.277 0.039 DBMET00834 0.268 0.043 DBMET00872 0.224 0.062 DBMET00845 0.347 0.024 DBMET00881 0.268 0.043 DBMET00874 0.347 0.024 DBMET00879 | DBMET00873 | |
| 0.34 | 0.006 | 0.34 | Nav1.3 sodium channel blocker | 0.335 0.007 DBMET00315 0.236 0.016 DBMET00873 0.208 0.022 DBMET00834 0.232 0.017 DBMET00872 0.232 0.017 DBMET00874 | ||
| 0.392 | 0.065 | 0.794 | Transcription factor NF kappa B inhibitor | 0.44 0.055 DBMET00315 0.207 0.163 DBMET00844 0.518 0.042 DBMET00873 0.447 0.054 DBMET00834 0.567 0.035 DBMET00872 0.611 0.03 DBMET00845 0.794 0.013 DBMET00881 0.567 0.035 DBMET00874 0.794 0.013 DBMET00879 | DBMET00879 | |
| 0.341 | 0.016 | 0.43 | MAO inhibitor | 0.285 0.022 DBMET00315 0.131 0.069 DBMET00844 0.43 0.01 DBMET00873 0.299 0.02 DBMET00834 0.37 0.014 DBMET00872 0.37 0.014 DBMET00874 | DBMET00873 | |
| 0.349 | 0.039 | 0.349 | Cardiotonic | 0.261 0.075 DBMET00315 0.287 0.062 DBMET00873 0.216 0.105 DBMET00834 0.214 0.107 DBMET00872 0.204 0.115 DBMET00881 0.214 0.107 DBMET00874 0.204 0.115 DBMET00879 | ||
| 0.313 | 0.004 | 0.315 | 5 Hydroxytryptamine 3E antagonist | 0.262 0.012 DBMET00531 0.315 0.004 DBMET00315 0.225 0.032 DBMET00844 0.251 0.015 DBMET00873 0.295 0.005 DBMET00834 0.253 0.014 DBMET00872 0.253 0.014 DBMET00874 | DBMET00315 | |
| 0.321 | 0.015 | 0.321 | 5 Hydroxytryptamine 2 antagonist | 0.286 0.017 DBMET00315 0.209 0.028 DBMET00873 0.166 0.039 DBMET00834 0.188 0.034 DBMET00872 0.188 0.034 DBMET00874 | ||
| 0.369 | 0.066 | 0.369 | Vasodilator, peripheral | 0.226 0.148 DBMET00531 0.27 0.114 DBMET00315 0.369 0.066 DBMET00873 0.27 0.114 DBMET00872 0.209 0.166 DBMET00845 0.342 0.077 DBMET00881 0.27 0.114 DBMET00874 0.342 0.077 DBMET00879 | ||
| 0.313 | 0.011 | 0.313 | 5 Hydroxytryptamine 2A antagonist | 0.26 0.014 DBMET00315 0.187 0.021 DBMET00873 0.148 0.029 DBMET00834 0.153 0.028 DBMET00872 0.153 0.028 DBMET00874 | ||
| 0.303 | 0.005 | 0.303 | 5 Hydroxytryptamine 7 antagonist | 0.206 0.012 DBMET00315 0.065 0.041 DBMET00844 0.197 0.013 DBMET00873 0.204 0.012 DBMET00834 0.117 0.022 DBMET00872 0.117 0.022 DBMET00874 | ||
| 0.336 | 0.042 | 0.336 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.255 0.101 DBMET00315 0.309 0.058 DBMET00873 0.324 0.048 DBMET00834 0.238 0.118 DBMET00872 0.238 0.118 DBMET00874 | ||
| 0.303 | 0.01 | 0.303 | 5 Hydroxytryptamine 1 antagonist | 0.228 0.014 DBMET00315 0.194 0.017 DBMET00873 0.123 0.029 DBMET00834 0.143 0.025 DBMET00872 0.143 0.025 DBMET00874 | ||
| 0.298 | 0.014 | 0.298 | Antipruritic | 0.298 0.015 DBMET00315 0.133 0.117 DBMET00844 0.295 0.015 DBMET00873 0.297 0.015 DBMET00834 0.295 0.015 DBMET00872 0.132 0.118 DBMET00845 0.199 0.05 DBMET00881 0.295 0.015 DBMET00874 0.199 0.05 DBMET00879 | ||
| 0.299 | 0.019 | 0.299 | 5 Hydroxytryptamine antagonist | 0.247 0.025 DBMET00315 0.167 0.043 DBMET00873 0.149 0.05 DBMET00834 0.136 0.056 DBMET00872 0.136 0.056 DBMET00874 | ||
| 0.295 | 0.016 | 0.295 | Alpha adrenoreceptor antagonist | 0.281 0.017 DBMET00315 0.247 0.02 DBMET00873 0.146 0.039 DBMET00834 0.237 0.022 DBMET00872 0.237 0.022 DBMET00874 | ||
| 0.29 | 0.012 | 0.352 | Topoisomerase I inhibitor | 0.204 0.025 DBMET00315 0.33 0.009 DBMET00844 0.319 0.009 DBMET00873 0.25 0.017 DBMET00834 0.247 0.017 DBMET00872 0.324 0.009 DBMET00845 0.352 0.008 DBMET00881 0.247 0.017 DBMET00874 0.352 0.008 DBMET00879 | DBMET00879 | |
| 0.281 | 0.005 | 0.281 | 5 Hydroxytryptamine 1D antagonist | 0.198 0.007 DBMET00315 0.172 0.009 DBMET00873 0.134 0.014 DBMET00834 0.123 0.016 DBMET00872 0.123 0.016 DBMET00874 | ||
| 0.388 | 0.118 | 0.467 | Caspase 9 stimulant | 0.429 0.095 DBMET00531 0.321 0.171 DBMET00315 0.467 0.074 DBMET00873 0.362 0.136 DBMET00834 0.397 0.113 DBMET00872 0.31 0.183 DBMET00845 0.437 0.09 DBMET00881 0.397 0.113 DBMET00874 0.437 0.09 DBMET00879 | DBMET00873 | |
| 0.285 | 0.017 | 0.285 | Acetylcholine M1 receptor antagonist | 0.232 0.03 DBMET00315 0.276 0.019 DBMET00873 0.232 0.03 DBMET00834 0.223 0.033 DBMET00872 0.223 0.033 DBMET00874 | ||
| 0.283 | 0.016 | 0.283 | 5 Hydroxytryptamine 2B antagonist | 0.2 0.027 DBMET00315 0.194 0.028 DBMET00873 0.152 0.04 DBMET00834 0.14 0.045 DBMET00872 0.14 0.045 DBMET00874 | ||
| 0.386 | 0.121 | 0.594 | Apoptosis agonist | 0.369 0.129 DBMET00315 0.451 0.091 DBMET00873 0.315 0.162 DBMET00834 0.436 0.097 DBMET00872 0.497 0.075 DBMET00845 0.594 0.05 DBMET00881 0.436 0.097 DBMET00874 0.594 0.05 DBMET00879 | DBMET00879 | |
| 0.275 | 0.015 | 0.275 | Anesthetic local | 0.223 0.026 DBMET00315 0.231 0.024 DBMET00873 0.13 0.06 DBMET00834 0.174 0.04 DBMET00872 0.174 0.04 DBMET00874 | ||
| 0.262 | 0.011 | 0.426 | ATPase inhibitor | 0.159 0.087 DBMET00531 0.252 0.013 DBMET00315 0.263 0.011 DBMET00873 0.176 0.062 DBMET00834 0.253 0.013 DBMET00872 0.252 0.013 DBMET00845 0.426 0.003 DBMET00881 0.253 0.013 DBMET00874 0.426 0.003 DBMET00879 | DBMET00879 | |
| 0.248 | 0.006 | 0.248 | 5 Hydroxytryptamine 1B antagonist | 0.188 0.009 DBMET00315 0.145 0.013 DBMET00873 0.109 0.02 DBMET00834 0.107 0.02 DBMET00872 0.107 0.02 DBMET00874 | ||
| 0.294 | 0.054 | 0.396 | Platelet antagonist | 0.291 0.056 DBMET00315 0.266 0.066 DBMET00873 0.378 0.032 DBMET00834 0.264 0.066 DBMET00872 0.34 0.041 DBMET00845 0.396 0.028 DBMET00881 0.264 0.066 DBMET00874 0.396 0.028 DBMET00879 | DBMET00879 | |
| 0.303 | 0.065 | 0.566 | Aldehyde oxidase inhibitor | 0.535 0.028 DBMET00531 0.566 0.024 DBMET00873 0.181 0.116 DBMET00872 0.181 0.116 DBMET00874 | DBMET00873 | |
| 0.252 | 0.021 | 0.252 | Nav1.2 sodium channel blocker | 0.239 0.024 DBMET00315 0.192 0.037 DBMET00873 0.216 0.029 DBMET00834 0.182 0.041 DBMET00872 0.182 0.041 DBMET00874 | ||
| 0.233 | 0.005 | 0.233 | Acetylcholine M4 receptor antagonist | 0.133 0.014 DBMET00315 0.086 0.041 DBMET00844 0.126 0.016 DBMET00873 0.112 0.021 DBMET00834 0.085 0.041 DBMET00872 0.085 0.041 DBMET00874 | ||
| 0.246 | 0.019 | 0.284 | Adenylate cyclase inhibitor | 0.096 0.088 DBMET00531 0.198 0.026 DBMET00315 0.284 0.015 DBMET00873 0.284 0.015 DBMET00834 0.242 0.02 DBMET00872 0.108 0.077 DBMET00845 0.177 0.031 DBMET00881 0.242 0.02 DBMET00874 0.177 0.031 DBMET00879 | DBMET00834 | |
| 0.275 | 0.057 | 0.387 | Vasodilator | 0.231 0.081 DBMET00315 0.288 0.052 DBMET00873 0.195 0.109 DBMET00834 0.248 0.07 DBMET00872 0.28 0.056 DBMET00845 0.387 0.025 DBMET00881 0.248 0.07 DBMET00874 0.387 0.025 DBMET00879 | DBMET00879 | |
| 0.222 | 0.005 | 0.446 | Adrenaline uptake inhibitor | 0.36 0.004 DBMET00315 0.446 0.004 DBMET00844 0.154 0.009 DBMET00873 0.145 0.01 DBMET00834 0.258 0.005 DBMET00872 0.102 0.018 DBMET00845 0.058 0.047 DBMET00881 0.258 0.005 DBMET00874 0.058 0.047 DBMET00879 | DBMET00844 | |
| 0.229 | 0.012 | 0.229 | 5 Hydroxytryptamine 1A antagonist | 0.163 0.018 DBMET00315 0.159 0.019 DBMET00873 0.106 0.03 DBMET00834 0.112 0.028 DBMET00872 0.112 0.028 DBMET00874 | ||
| 0.297 | 0.09 | 0.738 | Antithrombotic | 0.315 0.079 DBMET00315 0.315 0.079 DBMET00873 0.349 0.065 DBMET00834 0.337 0.069 DBMET00872 0.576 0.019 DBMET00845 0.738 0.006 DBMET00881 0.337 0.069 DBMET00874 0.738 0.006 DBMET00879 | DBMET00879 | |
| 0.224 | 0.026 | 0.224 | Cholinergic antagonist | 0.18 0.038 DBMET00315 0.203 0.031 DBMET00873 0.15 0.052 DBMET00834 0.165 0.045 DBMET00872 0.165 0.045 DBMET00874 | ||
| 0.223 | 0.027 | 0.223 | Acetylcholinesterase inhibitor | 0.157 0.051 DBMET00315 0.211 0.03 DBMET00873 0.157 0.051 DBMET00872 0.157 0.051 DBMET00874 | ||
| 0.213 | 0.022 | 0.216 | Antiadrenergic | 0.216 0.021 DBMET00315 0.181 0.028 DBMET00873 0.144 0.037 DBMET00834 0.184 0.027 DBMET00872 0.184 0.027 DBMET00874 | DBMET00315 | |
| 0.212 | 0.022 | 0.212 | Acetylcholine muscarinic antagonist | 0.159 0.039 DBMET00315 0.199 0.025 DBMET00873 0.138 0.051 DBMET00834 0.15 0.044 DBMET00872 0.15 0.044 DBMET00874 | ||
| 0.21 | 0.023 | 0.723 | DNA intercalator | 0.101 0.072 DBMET00315 0.723 0.003 DBMET00844 0.203 0.025 DBMET00873 0.09 0.086 DBMET00834 0.112 0.063 DBMET00872 0.387 0.008 DBMET00845 0.224 0.02 DBMET00881 0.112 0.063 DBMET00874 0.224 0.02 DBMET00879 | DBMET00844 | |
| 0.194 | 0.011 | 0.334 | Dopamine D1 antagonist | 0.134 0.017 DBMET00315 0.064 0.045 DBMET00844 0.334 0.005 DBMET00873 0.09 0.028 DBMET00834 0.25 0.008 DBMET00872 0.25 0.008 DBMET00874 | DBMET00873 | |
| 0.201 | 0.017 | 0.201 | 5 Hydroxytryptamine 2C antagonist | 0.177 0.021 DBMET00315 0.13 0.032 DBMET00873 0.117 0.037 DBMET00834 0.113 0.039 DBMET00872 0.113 0.039 DBMET00874 | ||
| 0.203 | 0.024 | 0.267 | MAO B inhibitor | 0.134 0.044 DBMET00315 0.267 0.015 DBMET00873 0.171 0.031 DBMET00834 0.181 0.028 DBMET00872 0.181 0.028 DBMET00874 | DBMET00873 | |
| 0.197 | 0.024 | 0.199 | Adrenaline antagonist | 0.199 0.024 DBMET00315 0.167 0.03 DBMET00873 0.127 0.041 DBMET00834 0.17 0.03 DBMET00872 0.17 0.03 DBMET00874 | DBMET00315 | |
| 0.194 | 0.022 | 0.194 | Alpha 1 adrenoreceptor antagonist | 0.184 0.023 DBMET00315 0.15 0.029 DBMET00873 0.081 0.052 DBMET00834 0.141 0.031 DBMET00872 0.141 0.031 DBMET00874 | ||
| 0.2 | 0.03 | 0.2 | Calcium channel blocker | 0.146 0.062 DBMET00315 0.127 0.079 DBMET00873 | ||
| 0.205 | 0.044 | 0.205 | Cholinergic | 0.145 0.081 DBMET00315 0.177 0.058 DBMET00873 0.132 0.094 DBMET00872 0.132 0.094 DBMET00874 | ||
| 0.18 | 0.024 | 0.231 | Nav1.4 sodium channel blocker | 0.177 0.025 DBMET00315 0.133 0.042 DBMET00844 0.174 0.025 DBMET00873 0.231 0.012 DBMET00834 0.173 0.026 DBMET00872 0.095 0.083 DBMET00881 0.173 0.026 DBMET00874 0.095 0.083 DBMET00879 | DBMET00834 | |
| 0.188 | 0.034 | 0.188 | Acetylcholine antagonist | 0.153 0.048 DBMET00315 0.171 0.04 DBMET00873 0.128 0.064 DBMET00834 0.139 0.056 DBMET00872 0.139 0.056 DBMET00874 | ||
| 0.173 | 0.018 | 0.189 | Alpha 1b adrenoreceptor antagonist | 0.189 0.016 DBMET00315 0.142 0.024 DBMET00873 0.094 0.038 DBMET00834 0.157 0.021 DBMET00872 0.157 0.021 DBMET00874 | DBMET00315 | |
| 0.239 | 0.087 | 0.468 | DNA damaging | 0.214 0.104 DBMET00315 0.468 0.017 DBMET00844 0.265 0.072 DBMET00873 0.264 0.073 DBMET00834 0.238 0.088 DBMET00872 0.319 0.05 DBMET00845 0.295 0.059 DBMET00881 0.238 0.088 DBMET00874 0.295 0.059 DBMET00879 | DBMET00844 | |
| 0.24 | 0.094 | 0.511 | 5 Hydroxytryptamine release stimulant | 0.49 0.029 DBMET00531 0.479 0.031 DBMET00315 0.269 0.081 DBMET00873 0.472 0.032 DBMET00834 0.511 0.025 DBMET00872 0.511 0.025 DBMET00874 | DBMET00874 | |
| 0.153 | 0.007 | 0.153 | Acetylcholine M5 receptor antagonist | 0.115 0.014 DBMET00315 0.125 0.011 DBMET00873 0.073 0.028 DBMET00834 0.089 0.021 DBMET00872 0.089 0.021 DBMET00874 | ||
| 0.162 | 0.022 | 0.162 | Alpha 1a adrenoreceptor antagonist | 0.161 0.022 DBMET00315 0.116 0.031 DBMET00873 0.069 0.051 DBMET00834 0.116 0.031 DBMET00872 0.116 0.031 DBMET00874 | ||
| 0.175 | 0.035 | 0.258 | MAO A inhibitor | 0.164 0.037 DBMET00315 0.258 0.02 DBMET00873 0.134 0.046 DBMET00834 0.246 0.021 DBMET00872 0.246 0.021 DBMET00874 | DBMET00873 | |
| 0.163 | 0.024 | 0.163 | Dopamine antagonist | 0.122 0.031 DBMET00315 0.158 0.024 DBMET00873 0.073 0.051 DBMET00834 0.119 0.032 DBMET00872 0.119 0.032 DBMET00874 | ||
| 0.148 | 0.01 | 0.182 | Histamine H2 receptor antagonist | 0.182 0.006 DBMET00315 0.105 0.03 DBMET00873 0.117 0.022 DBMET00834 0.126 0.018 DBMET00872 0.126 0.018 DBMET00874 | DBMET00315 | |
| 0.211 | 0.074 | 0.211 | Platelet aggregation inhibitor | 0.172 0.105 DBMET00315 0.186 0.092 DBMET00873 0.175 0.102 DBMET00834 0.156 0.121 DBMET00872 0.162 0.115 DBMET00881 0.156 0.121 DBMET00874 0.162 0.115 DBMET00879 | ||
| 0.133 | 0.004 | 0.133 | 5 Hydroxytryptamine 3B antagonist | 0.095 0.005 DBMET00315 0.032 0.03 DBMET00844 0.064 0.01 DBMET00873 0.062 0.01 DBMET00834 0.043 0.019 DBMET00872 0.043 0.019 DBMET00874 | ||
| 0.144 | 0.015 | 0.151 | Alpha 1d adrenoreceptor antagonist | 0.151 0.014 DBMET00315 0.104 0.022 DBMET00873 0.072 0.034 DBMET00834 0.111 0.021 DBMET00872 0.111 0.021 DBMET00874 | DBMET00315 | |
| 0.2 | 0.072 | 0.254 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.243 0.046 DBMET00531 0.254 0.041 DBMET00873 0.164 0.118 DBMET00834 0.162 0.122 DBMET00872 0.177 0.097 DBMET00881 0.162 0.122 DBMET00874 0.177 0.097 DBMET00879 | DBMET00873 | |
| 0.173 | 0.047 | 0.173 | Cytokine production inhibitor | 0.144 0.067 DBMET00873 0.146 0.065 DBMET00834 | ||
| 0.133 | 0.012 | 0.133 | Dopamine uptake inhibitor | 0.122 0.014 DBMET00315 0.095 0.02 DBMET00873 0.068 0.032 DBMET00834 0.088 0.022 DBMET00872 0.088 0.022 DBMET00874 | ||
| 0.146 | 0.029 | 0.173 | Antineoplastic alkaloid | 0.173 0.021 DBMET00873 0.092 0.053 DBMET00872 0.092 0.053 DBMET00874 | DBMET00873 | |
| 0.123 | 0.009 | 0.177 | Beta 3 adrenoreceptor antagonist | 0.131 0.008 DBMET00315 0.164 0.005 DBMET00873 0.078 0.025 DBMET00834 0.177 0.004 DBMET00872 0.177 0.004 DBMET00874 | DBMET00874 | |
| 0.259 | 0.146 | 0.592 | GABA C receptor rho-3 antagonist | 0.592 0.008 DBMET00531 0.277 0.132 DBMET00315 0.264 0.142 DBMET00873 0.309 0.11 DBMET00834 0.281 0.129 DBMET00872 0.281 0.129 DBMET00874 | DBMET00531 | |
| 0.142 | 0.032 | 0.162 | Nav1.5 sodium channel blocker | 0.162 0.021 DBMET00315 0.103 0.079 DBMET00873 0.157 0.024 DBMET00834 0.119 0.055 DBMET00872 0.119 0.055 DBMET00874 | DBMET00315 | |
| 0.137 | 0.027 | 0.137 | Calcium antagonist | 0.082 0.062 DBMET00531 | ||
| 0.127 | 0.019 | 0.127 | Dopamine D3 antagonist | 0.099 0.025 DBMET00315 0.101 0.024 DBMET00873 0.08 0.032 DBMET00872 0.08 0.032 DBMET00874 | ||
| 0.138 | 0.03 | 0.263 | Estrogen antagonist | 0.124 0.047 DBMET00315 0.161 0.02 DBMET00844 0.263 0.008 DBMET00873 0.122 0.052 DBMET00834 0.218 0.011 DBMET00872 0.116 0.062 DBMET00845 0.125 0.047 DBMET00881 0.218 0.011 DBMET00874 0.125 0.047 DBMET00879 | DBMET00873 | |
| 0.143 | 0.037 | 0.143 | Butyrylcholinesterase inhibitor | 0.125 0.044 DBMET00873 | ||
| 0.192 | 0.089 | 0.254 | Antimitotic | 0.254 0.058 DBMET00844 0.214 0.077 DBMET00873 0.217 0.075 DBMET00834 0.158 0.114 DBMET00872 0.137 0.136 DBMET00881 0.158 0.114 DBMET00874 0.137 0.136 DBMET00879 | DBMET00844 | |
| 0.113 | 0.011 | 0.113 | 5 Hydroxytryptamine 6 antagonist | 0.088 0.019 DBMET00315 0.064 0.033 DBMET00873 0.076 0.026 DBMET00834 | ||
| 0.139 | 0.038 | 0.197 | Photosensitizer | 0.141 0.037 DBMET00531 0.135 0.042 DBMET00873 0.11 0.071 DBMET00834 0.197 0.013 DBMET00881 0.197 0.013 DBMET00879 | DBMET00879 | |
| 0.105 | 0.005 | 0.105 | 5 Hydroxytryptamine 4 antagonist | 0.1 0.006 DBMET00315 0.073 0.016 DBMET00873 0.097 0.007 DBMET00834 0.068 0.018 DBMET00872 0.068 0.018 DBMET00874 | ||
| 0.149 | 0.049 | 0.163 | Heat shock protein 70 antagonist | 0.149 0.049 DBMET00531 0.135 0.096 DBMET00315 0.159 0.03 DBMET00873 0.154 0.037 DBMET00834 0.144 0.063 DBMET00872 0.163 0.024 DBMET00881 0.144 0.063 DBMET00874 0.163 0.024 DBMET00879 | DBMET00879 | |
| 0.116 | 0.017 | 0.116 | Calcium channel L-type blocker | 0.085 0.034 DBMET00315 0.079 0.04 DBMET00873 | ||
| 0.123 | 0.027 | 0.123 | Dopamine D2 antagonist | 0.083 0.038 DBMET00315 0.118 0.028 DBMET00873 0.079 0.04 DBMET00872 0.079 0.04 DBMET00874 | ||
| 0.212 | 0.117 | 0.238 | 5 Hydroxytryptamine 1E antagonist | 0.238 0.088 DBMET00531 0.23 0.097 DBMET00315 0.209 0.12 DBMET00873 0.227 0.1 DBMET00872 0.227 0.1 DBMET00874 | DBMET00531 | |
| 0.152 | 0.057 | 0.152 | Neurotrophic factor | 0.113 0.107 DBMET00315 0.145 0.064 DBMET00873 0.114 0.106 DBMET00872 0.133 0.077 DBMET00881 0.114 0.106 DBMET00874 0.133 0.077 DBMET00879 | ||
| 0.101 | 0.007 | 0.101 | Potassium channel (Inward rectifier) blocker | 0.085 0.01 DBMET00315 0.061 0.023 DBMET00873 0.055 0.028 DBMET00834 0.049 0.035 DBMET00872 0.049 0.035 DBMET00874 | ||
| 0.106 | 0.013 | 0.129 | Androgen agonist | 0.058 0.044 DBMET00531 0.087 0.021 DBMET00315 0.071 0.03 DBMET00844 0.129 0.009 DBMET00873 0.087 0.02 DBMET00834 0.104 0.013 DBMET00872 0.104 0.013 DBMET00874 | DBMET00873 | |
| 0.111 | 0.018 | 0.111 | Acetylcholine M2 receptor antagonist | 0.074 0.034 DBMET00315 0.089 0.025 DBMET00873 0.062 0.043 DBMET00834 0.061 0.044 DBMET00872 0.061 0.044 DBMET00874 | ||
| 0.121 | 0.031 | 0.235 | Estrogen receptor beta antagonist | 0.111 0.045 DBMET00315 0.094 0.076 DBMET00844 0.235 0.007 DBMET00873 0.112 0.043 DBMET00834 0.193 0.01 DBMET00872 0.193 0.01 DBMET00874 | DBMET00873 | |
| 0.106 | 0.017 | 0.122 | Acetylcholine M3 receptor antagonist | 0.083 0.025 DBMET00315 0.122 0.014 DBMET00873 0.063 0.038 DBMET00834 0.091 0.021 DBMET00872 0.091 0.021 DBMET00874 | DBMET00873 | |
| 0.085 | 0.003 | 0.111 | Estrogen-related receptor beta antagonist | 0.062 0.004 DBMET00315 0.06 0.004 DBMET00844 0.111 0.002 DBMET00873 0.068 0.004 DBMET00834 0.086 0.003 DBMET00872 0.037 0.014 DBMET00845 0.044 0.008 DBMET00881 0.086 0.003 DBMET00874 0.044 0.008 DBMET00879 | DBMET00873 | |
| 0.148 | 0.066 | 0.185 | Adenylate cyclase stimulant | 0.185 0.022 DBMET00531 0.163 0.044 DBMET00315 0.164 0.042 DBMET00873 0.159 0.048 DBMET00834 0.179 0.026 DBMET00872 0.179 0.026 DBMET00874 | DBMET00531 | |
| 0.096 | 0.019 | 0.096 | 5 Hydroxytryptamine 3 antagonist | 0.059 0.036 DBMET00315 0.061 0.034 DBMET00834 | ||
| 0.125 | 0.051 | 0.125 | Calcium channel (voltage-sensitive) blocker | 0.1 0.084 DBMET00315 | ||
| 0.099 | 0.028 | 0.22 | Estrogen receptor alpha antagonist | 0.071 0.066 DBMET00315 0.22 0.007 DBMET00873 0.07 0.069 DBMET00834 0.119 0.019 DBMET00872 0.119 0.019 DBMET00874 | DBMET00873 | |
| 0.081 | 0.02 | 0.087 | Thromboxane antagonist | 0.087 0.016 DBMET00315 0.049 0.042 DBMET00844 0.074 0.024 DBMET00873 0.079 0.02 DBMET00834 0.081 0.02 DBMET00872 0.081 0.02 DBMET00874 | DBMET00315 | |
| 0.131 | 0.07 | 0.172 | Tubulin antagonist | 0.121 0.079 DBMET00315 0.172 0.048 DBMET00873 0.124 0.076 DBMET00834 0.16 0.054 DBMET00872 0.16 0.054 DBMET00874 | DBMET00873 | |
| 0.077 | 0.017 | 0.083 | Thromboxane A2 antagonist | 0.083 0.013 DBMET00315 0.051 0.035 DBMET00844 0.071 0.021 DBMET00873 0.076 0.017 DBMET00834 0.077 0.017 DBMET00872 0.077 0.017 DBMET00874 | DBMET00315 | |
| 0.124 | 0.064 | 0.213 | DNA repair enzyme inhibitor | 0.114 0.085 DBMET00531 0.108 0.103 DBMET00315 0.167 0.019 DBMET00844 0.118 0.076 DBMET00873 0.206 0.008 DBMET00845 0.213 0.007 DBMET00881 0.213 0.007 DBMET00879 | DBMET00879 | |
| 0.095 | 0.036 | 0.26 | Telomerase inhibitor | 0.26 0.009 DBMET00844 0.078 0.045 DBMET00873 | DBMET00844 | |
| 0.097 | 0.037 | 0.149 | CYP2A6 inhibitor | 0.111 0.031 DBMET00531 0.109 0.032 DBMET00315 0.149 0.017 DBMET00834 | DBMET00834 | |
| 0.08 | 0.02 | 0.08 | Sigma receptor antagonist | 0.046 0.037 DBMET00315 0.064 0.026 DBMET00873 | ||
| 0.112 | 0.053 | 0.202 | Carbonic anhydrase XV inhibitor | 0.134 0.038 DBMET00531 0.096 0.073 DBMET00315 0.14 0.034 DBMET00873 0.202 0.018 DBMET00834 0.118 0.048 DBMET00872 0.118 0.048 DBMET00874 | DBMET00834 | |
| 0.101 | 0.045 | 0.112 | Histamine N-methyltransferase inhibitor | 0.112 0.035 DBMET00531 0.094 0.051 DBMET00873 | DBMET00531 | |
| 0.121 | 0.066 | 0.283 | Topoisomerase II inhibitor | 0.173 0.04 DBMET00844 0.191 0.035 DBMET00873 0.125 0.063 DBMET00872 0.216 0.03 DBMET00845 0.283 0.02 DBMET00881 0.125 0.063 DBMET00874 0.283 0.02 DBMET00879 | DBMET00879 | |
| 0.105 | 0.05 | 0.145 | Prolactin inhibitor | 0.145 0.024 DBMET00531 0.14 0.026 DBMET00873 | DBMET00531 | |
| 0.075 | 0.022 | 0.115 | Beta 1 adrenoreceptor antagonist | 0.094 0.012 DBMET00315 0.088 0.014 DBMET00873 0.066 0.03 DBMET00834 0.115 0.008 DBMET00872 0.115 0.008 DBMET00874 | DBMET00874 | |
| 0.13 | 0.077 | 0.138 | Toll-Like receptor 9 antagonist | 0.138 0.071 DBMET00315 0.105 0.104 DBMET00873 0.111 0.097 DBMET00872 0.111 0.097 DBMET00874 | DBMET00315 | |
| 0.07 | 0.018 | 0.08 | 5 Hydroxytryptamine 1B agonist | 0.08 0.013 DBMET00315 0.055 0.032 DBMET00873 0.059 0.028 DBMET00834 0.063 0.023 DBMET00872 0.063 0.023 DBMET00874 | DBMET00315 | |
| 0.079 | 0.028 | 0.131 | Beta adrenoreceptor antagonist | 0.104 0.015 DBMET00315 0.105 0.014 DBMET00873 0.073 0.034 DBMET00834 0.131 0.008 DBMET00872 0.131 0.008 DBMET00874 | DBMET00874 | |
| 0.155 | 0.104 | 0.282 | Amyloid beta aggregation inhibitor | 0.282 0.049 DBMET00873 0.129 0.127 DBMET00834 0.226 0.066 DBMET00872 0.192 0.082 DBMET00881 0.226 0.066 DBMET00874 0.192 0.082 DBMET00879 | DBMET00873 | |
| 0.261 | 0.213 | 0.464 | 5 Hydroxytryptamine release inhibitor | 0.464 0.046 DBMET00531 0.266 0.206 DBMET00315 0.277 0.192 DBMET00873 0.378 0.093 DBMET00834 0.282 0.186 DBMET00872 0.267 0.205 DBMET00845 0.339 0.125 DBMET00881 0.282 0.186 DBMET00874 0.339 0.125 DBMET00879 | DBMET00531 | |
| 0.189 | 0.141 | 0.204 | Neuropeptide Y2 antagonist | 0.191 0.137 DBMET00531 0.181 0.158 DBMET00873 0.204 0.113 DBMET00834 | DBMET00834 | |
| 0.154 | 0.109 | 0.392 | Non-steroidal antiinflammatory agent | 0.153 0.112 DBMET00315 0.172 0.093 DBMET00873 0.161 0.103 DBMET00834 0.17 0.095 DBMET00872 0.168 0.097 DBMET00845 0.392 0.014 DBMET00881 0.17 0.095 DBMET00874 0.392 0.014 DBMET00879 | DBMET00879 | |
| 0.077 | 0.034 | 0.077 | Dopamine D4 antagonist | 0.058 0.043 DBMET00873 | ||
| 0.06 | 0.017 | 0.078 | Adenylate cyclase 1 inhibitor | 0.078 0.009 DBMET00531 0.045 0.034 DBMET00315 0.048 0.029 DBMET00873 0.044 0.035 DBMET00834 | DBMET00531 | |
| 0.088 | 0.046 | 0.111 | Estrogen-related receptor beta agonist | 0.108 0.017 DBMET00531 0.111 0.015 DBMET00873 0.088 0.044 DBMET00872 0.088 0.044 DBMET00874 | DBMET00873 | |
| 0.074 | 0.032 | 0.115 | Beta tubulin antagonist | 0.08 0.029 DBMET00315 0.111 0.019 DBMET00873 0.053 0.044 DBMET00834 0.115 0.019 DBMET00872 0.115 0.019 DBMET00874 | DBMET00874 | |
| 0.056 | 0.015 | 0.242 | Kinesin-like protein 1 inhibitor | 0.242 0.004 DBMET00844 0.064 0.013 DBMET00873 0.131 0.005 DBMET00834 | DBMET00844 | |
| 0.056 | 0.015 | 0.242 | Kinesin antagonist | 0.242 0.004 DBMET00844 0.064 0.013 DBMET00873 0.131 0.005 DBMET00834 | DBMET00844 | |
| 0.107 | 0.067 | 0.235 | GABA C receptor antagonist | 0.235 0.008 DBMET00531 0.098 0.08 DBMET00315 0.101 0.076 DBMET00873 0.171 0.021 DBMET00834 0.093 0.09 DBMET00872 0.093 0.09 DBMET00874 | DBMET00531 | |
| 0.142 | 0.103 | 0.167 | Dual specificity phosphatase inhibitor | 0.167 0.077 DBMET00873 | DBMET00873 | |
| 0.046 | 0.007 | 0.046 | Urotensin II agonist | 0.041 0.009 DBMET00873 0.025 0.022 DBMET00834 | ||
| 0.062 | 0.025 | 0.068 | 5 Hydroxytryptamine 2 agonist | 0.068 0.02 DBMET00315 0.066 0.021 DBMET00834 0.045 0.043 DBMET00872 0.045 0.043 DBMET00874 | DBMET00315 | |
| 0.041 | 0.005 | 0.041 | Prostaglandin H2 antagonist | 0.037 0.007 DBMET00315 0.033 0.01 DBMET00844 0.037 0.008 DBMET00873 0.041 0.005 DBMET00834 0.032 0.011 DBMET00872 0.032 0.011 DBMET00874 | ||
| 0.173 | 0.139 | 0.561 | Antioxidant | 0.166 0.146 DBMET00315 0.307 0.059 DBMET00873 0.194 0.118 DBMET00834 0.294 0.064 DBMET00872 0.43 0.03 DBMET00845 0.561 0.014 DBMET00881 0.294 0.064 DBMET00874 0.561 0.014 DBMET00879 | DBMET00879 | |
| 0.059 | 0.028 | 0.072 | Thromboxane synthase inhibitor | 0.072 0.016 DBMET00315 0.055 0.036 DBMET00873 0.061 0.026 DBMET00834 0.066 0.02 DBMET00872 0.066 0.02 DBMET00874 | DBMET00315 | |
| 0.092 | 0.062 | 0.131 | Alcohol dehydrogenase inhibitor | 0.096 0.057 DBMET00531 0.131 0.028 DBMET00873 0.112 0.041 DBMET00834 0.11 0.043 DBMET00872 0.109 0.043 DBMET00881 0.11 0.043 DBMET00874 0.109 0.043 DBMET00879 | DBMET00873 | |
| 0.062 | 0.034 | 0.062 | Bcl-xL inhibitor | 0.061 0.036 DBMET00873 | ||
| 0.108 | 0.081 | 0.108 | Calcium channel N-type blocker | |||
| 0.055 | 0.03 | 0.098 | Beta 2 adrenoreceptor antagonist | 0.073 0.015 DBMET00315 0.073 0.015 DBMET00873 0.054 0.031 DBMET00834 0.098 0.008 DBMET00872 0.098 0.008 DBMET00874 | DBMET00874 | |
| 0.077 | 0.054 | 0.111 | Na+ K+ transporting ATPase inhibitor | 0.1 0.031 DBMET00531 0.081 0.049 DBMET00873 0.083 0.047 DBMET00834 0.094 0.037 DBMET00845 0.111 0.022 DBMET00881 0.111 0.022 DBMET00879 | DBMET00879 | |
| 0.114 | 0.092 | 0.141 | Sodium channel (voltage-gated) blocker | 0.141 0.061 DBMET00315 0.137 0.066 DBMET00834 | DBMET00315 | |
| 0.185 | 0.165 | 0.372 | Tyrosine 3 hydroxylase inhibitor | 0.372 0.012 DBMET00531 0.191 0.152 DBMET00315 0.216 0.11 DBMET00873 0.24 0.078 DBMET00834 0.223 0.099 DBMET00872 0.223 0.099 DBMET00874 | DBMET00531 | |
| 0.113 | 0.093 | 0.135 | Sodium channel blocker | 0.135 0.07 DBMET00315 0.124 0.079 DBMET00834 | DBMET00315 | |
| 0.04 | 0.021 | 0.049 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.049 0.012 DBMET00844 | DBMET00844 | |
| 0.051 | 0.032 | 0.056 | Squalene epoxidase inhibitor | 0.056 0.025 DBMET00531 0.054 0.028 DBMET00873 | DBMET00531 | |
| 0.112 | 0.093 | 0.148 | Bone formation stimulant | 0.148 0.061 DBMET00873 0.136 0.071 DBMET00834 0.132 0.075 DBMET00872 0.13 0.076 DBMET00881 0.132 0.075 DBMET00874 0.13 0.076 DBMET00879 | DBMET00873 | |
| 0.18 | 0.163 | 0.318 | Lipoxygenase inhibitor | 0.198 0.143 DBMET00315 0.294 0.074 DBMET00873 0.213 0.127 DBMET00834 0.318 0.062 DBMET00872 0.318 0.062 DBMET00874 | DBMET00874 | |
| 0.066 | 0.05 | 0.125 | Protein kinase C alpha inhibitor | 0.125 0.015 DBMET00844 0.07 0.044 DBMET00834 | DBMET00844 | |
| 0.106 | 0.091 | 0.109 | RET inhibitor | 0.109 0.087 DBMET00315 | DBMET00315 | |
| 0.048 | 0.033 | 0.078 | Dopamine transporter inhibitor | 0.073 0.019 DBMET00315 0.078 0.018 DBMET00844 0.05 0.032 DBMET00872 0.05 0.032 DBMET00874 | DBMET00844 | |
| 0.035 | 0.02 | 0.052 | Melatonin receptor 1A agonist | 0.033 0.024 DBMET00531 0.052 0.007 DBMET00315 0.032 0.026 DBMET00834 0.038 0.016 DBMET00872 0.038 0.016 DBMET00874 | DBMET00315 | |
| 0.029 | 0.017 | 0.036 | Estrogen-related receptor gamma antagonist | 0.032 0.013 DBMET00531 0.036 0.007 DBMET00873 | DBMET00873 | |
| 0.051 | 0.04 | 0.051 | Acetyl-CoA transferase inhibitor | |||
| 0.14 | 0.131 | 0.303 | Succinate dehydrogenase inhibitor | 0.303 0.01 DBMET00531 0.145 0.121 DBMET00315 0.149 0.114 DBMET00873 0.183 0.064 DBMET00834 0.154 0.105 DBMET00872 0.154 0.105 DBMET00874 | DBMET00531 | |
| 0.03 | 0.021 | 0.03 | Potassium channel (Inward rectifier) 1 blocker | |||
| 0.189 | 0.181 | 0.189 | Thioredoxin glutathione reductase inhibitor | |||
| 0.045 | 0.038 | 0.059 | Mineralocorticoid receptor antagonist | 0.046 0.036 DBMET00315 0.059 0.021 DBMET00834 | DBMET00834 | |
| 0.032 | 0.024 | 0.056 | Melatonin 2 agonist | 0.056 0.009 DBMET00315 0.033 0.023 DBMET00873 0.031 0.026 DBMET00834 0.052 0.01 DBMET00872 0.052 0.01 DBMET00874 | DBMET00315 | |
| 0.087 | 0.079 | 0.137 | Carbonic anhydrase III inhibitor | 0.115 0.048 DBMET00531 0.137 0.034 DBMET00873 0.125 0.041 DBMET00834 0.098 0.065 DBMET00872 0.098 0.065 DBMET00874 | DBMET00873 | |
| 0.03 | 0.025 | 0.043 | Estrogen-related receptor alpha antagonist | 0.043 0.016 DBMET00873 0.035 0.02 DBMET00872 0.035 0.02 DBMET00874 | DBMET00873 | |
| 0.049 | 0.044 | 0.181 | Acyl-CoA dehydrogenase inhibitor | 0.181 0.006 DBMET00531 | DBMET00531 | |
| 0.024 | 0.02 | 0.024 | Sigma 2 receptor antagonist | 0.024 0.02 DBMET00873 | ||
| 0.081 | 0.08 | 0.156 | 5-Lipoxygenase inhibitor | 0.094 0.068 DBMET00315 0.148 0.039 DBMET00873 0.103 0.062 DBMET00834 0.156 0.036 DBMET00872 0.156 0.036 DBMET00874 | DBMET00874 | |
| 0.034 | 0.033 | 0.042 | Delayed rectifier potassium channel blocker | 0.036 0.028 DBMET00531 0.042 0.018 DBMET00315 0.038 0.024 DBMET00872 0.038 0.024 DBMET00874 | DBMET00315 | |
| 0.118 | 0.117 | 0.146 | Sigma receptor agonist | 0.146 0.088 DBMET00873 | DBMET00873 | |
| 0.018 | 0.019 | 0.036 | Imidazoline I1 receptor antagonist | 0.019 0.017 DBMET00531 0.036 0.005 DBMET00834 | DBMET00834 | |
| 0.11 | 0.112 | 0.153 | Papain-like protease (SARS coronavirus) inhibitor | 0.136 0.051 DBMET00315 0.133 0.055 DBMET00873 0.119 0.085 DBMET00834 0.153 0.031 DBMET00872 0.153 0.031 DBMET00874 | DBMET00874 | |
| 0.136 | 0.138 | 0.18 | Phospholipase C inhibitor | 0.18 0.061 DBMET00531 0.158 0.092 DBMET00873 0.165 0.079 DBMET00834 | DBMET00531 | |
| 0.148 | 0.151 | 0.301 | Antiamyloidogenic | 0.157 0.138 DBMET00315 0.216 0.089 DBMET00873 0.15 0.147 DBMET00834 0.23 0.081 DBMET00872 0.301 0.051 DBMET00881 0.23 0.081 DBMET00874 0.301 0.051 DBMET00879 | DBMET00879 | |
| 0.124 | 0.127 | 0.281 | Melanin inhibitor | 0.154 0.076 DBMET00531 0.125 0.123 DBMET00315 0.167 0.061 DBMET00873 0.164 0.065 DBMET00834 0.169 0.06 DBMET00872 0.172 0.057 DBMET00845 0.281 0.024 DBMET00881 0.169 0.06 DBMET00874 0.281 0.024 DBMET00879 | DBMET00879 | |
| 0.182 | 0.186 | 0.274 | Insulysin inhibitor | 0.274 0.076 DBMET00531 0.202 0.154 DBMET00315 0.192 0.169 DBMET00873 0.217 0.132 DBMET00834 0.212 0.14 DBMET00872 0.212 0.14 DBMET00874 | DBMET00531 | |
| 0.018 | 0.022 | 0.034 | Dopamine autoreceptor agonist | 0.027 0.015 DBMET00315 0.023 0.017 DBMET00873 0.034 0.011 DBMET00872 0.034 0.011 DBMET00874 | DBMET00874 | |
| 0.064 | 0.068 | 0.119 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.078 0.053 DBMET00531 0.119 0.029 DBMET00844 0.105 0.035 DBMET00873 | DBMET00844 | |
| 0.052 | 0.056 | 0.079 | 5 Hydroxytryptamine 2A agonist | 0.058 0.048 DBMET00315 0.079 0.028 DBMET00834 | DBMET00834 | |
| 0.047 | 0.051 | 0.08 | Leukotriene B4 antagonist | 0.056 0.033 DBMET00873 0.053 0.038 DBMET00845 0.08 0.015 DBMET00881 0.08 0.015 DBMET00879 | DBMET00879 | |
| 0.043 | 0.048 | 0.056 | Topoisomerase II beta inhibitor | 0.048 0.037 DBMET00531 0.056 0.026 DBMET00873 | DBMET00873 | |
| 0.012 | 0.017 | 0.015 | NMDA receptor phencyclidine site antagonist | 0.015 0.011 DBMET00873 | DBMET00873 | |
| 0.149 | 0.154 | 0.301 | Cyclic AMP phosphodiesterase inhibitor | 0.17 0.122 DBMET00531 0.163 0.131 DBMET00873 0.301 0.042 DBMET00881 0.301 0.042 DBMET00879 | DBMET00879 | |
| 0.073 | 0.079 | 0.095 | Myeloperoxidase inhibitor | 0.081 0.065 DBMET00315 0.082 0.063 DBMET00873 0.095 0.042 DBMET00834 0.088 0.051 DBMET00872 0.088 0.051 DBMET00874 | DBMET00834 | |
| 0.03 | 0.037 | 0.038 | Opioid delta receptor agonist | 0.038 0.021 DBMET00873 0.035 0.025 DBMET00834 0.036 0.023 DBMET00872 0.036 0.023 DBMET00874 | DBMET00873 | |
| 0.119 | 0.128 | 0.253 | GABA C receptor rho-2 antagonist | 0.253 0.011 DBMET00531 0.159 0.062 DBMET00315 0.124 0.117 DBMET00834 0.16 0.061 DBMET00872 0.16 0.061 DBMET00874 | DBMET00531 | |
| 0.029 | 0.041 | 0.033 | Ceramide glucosyltransferase inhibitor | 0.033 0.029 DBMET00531 | DBMET00531 | |
| 0.033 | 0.047 | 0.045 | Opioid kappa receptor agonist | 0.045 0.028 DBMET00873 0.038 0.037 DBMET00872 0.038 0.037 DBMET00874 | DBMET00873 | |
| 0.016 | 0.03 | 0.021 | Leukotriene B4 receptor 2 antagonist | 0.021 0.017 DBMET00881 0.021 0.017 DBMET00879 | DBMET00879 | |
| 0.025 | 0.042 | 0.04 | Melatonin 1 agonist | 0.04 0.015 DBMET00315 0.035 0.02 DBMET00872 0.035 0.02 DBMET00874 | DBMET00315 | |
| 0.038 | 0.055 | 0.048 | Aldosterone antagonist | 0.048 0.032 DBMET00531 | DBMET00531 | |
| 0.028 | 0.046 | 0.044 | Dopamine D5 antagonist | 0.044 0.029 DBMET00873 | DBMET00873 | |
| 0.073 | 0.092 | 0.098 | mTOR complex 2 inhibitor | 0.098 0.035 DBMET00531 0.08 0.068 DBMET00315 | DBMET00531 | |
| 0.179 | 0.2 | 0.402 | 5 Hydroxytryptamine uptake stimulant | 0.402 0.014 DBMET00531 0.236 0.096 DBMET00834 | DBMET00531 | |
| 0.023 | 0.045 | 0.04 | Melatonin agonist | 0.04 0.015 DBMET00315 0.034 0.021 DBMET00872 0.034 0.021 DBMET00874 | DBMET00315 | |
| 0.008 | 0.032 | 0.016 | Melatonin receptor 1A antagonist | 0.016 0.007 DBMET00315 | DBMET00315 | |
| 0.058 | 0.083 | 0.085 | Analgesic, opioid | 0.085 0.042 DBMET00873 0.078 0.05 DBMET00872 0.078 0.05 DBMET00874 | DBMET00873 | |
| 0.043 | 0.068 | 0.056 | Nicotinic alpha3beta2 receptor antagonist | 0.056 0.032 DBMET00531 | DBMET00531 | |
| 0.03 | 0.056 | 0.038 | Histone deacetylase 9 inhibitor | 0.038 0.03 DBMET00315 | DBMET00315 | |
| 0.112 | 0.14 | 0.148 | Dual specificity phosphatase 3 inhibitor | 0.148 0.098 DBMET00873 | DBMET00873 | |
| 0.159 | 0.186 | 0.301 | DNA synthesis inhibitor | 0.26 0.06 DBMET00531 0.28 0.051 DBMET00845 0.301 0.043 DBMET00881 0.301 0.043 DBMET00879 | DBMET00879 | |
| 0.254 | 0.281 | 0.514 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.514 0.028 DBMET00531 0.346 0.155 DBMET00315 | DBMET00531 | |
| 0.029 | 0.057 | 0.068 | ATM kinase inhibitor | 0.068 0.004 DBMET00844 | DBMET00844 | |
| 0.055 | 0.083 | 0.173 | Topoisomerase II alpha inhibitor | 0.105 0.036 DBMET00873 0.075 0.057 DBMET00872 0.088 0.048 DBMET00845 0.173 0.019 DBMET00881 0.075 0.057 DBMET00874 0.173 0.019 DBMET00879 | DBMET00879 | |
| 0.047 | 0.075 | 0.058 | Leukotriene antagonist | 0.058 0.054 DBMET00873 | DBMET00873 | |
| 0.019 | 0.048 | 0.025 | Integrin alpha2beta1 antagonist | 0.025 0.022 DBMET00531 | DBMET00531 | |
| 0.167 | 0.198 | 0.253 | Gastrin inhibitor | 0.253 0.076 DBMET00531 0.212 0.131 DBMET00315 | DBMET00531 | |
| 0.081 | 0.114 | 0.127 | Glutamate (mGluR7) agonist | 0.121 0.03 DBMET00531 0.127 0.024 DBMET00315 0.095 0.072 DBMET00834 | DBMET00315 | |
| 0.182 | 0.216 | 0.466 | Immunosuppressant | 0.221 0.175 DBMET00873 0.203 0.194 DBMET00834 0.209 0.187 DBMET00872 0.375 0.074 DBMET00845 0.466 0.042 DBMET00881 0.209 0.187 DBMET00874 0.466 0.042 DBMET00879 | DBMET00879 | |
| 0.016 | 0.052 | 0.086 | Sodium/glucose cotransporter 2 inhibitor | 0.049 0.006 DBMET00845 0.086 0.004 DBMET00881 0.086 0.004 DBMET00879 | DBMET00879 | |
| 0.06 | 0.096 | 0.081 | Interferon agonist | 0.081 0.051 DBMET00531 0.071 0.069 DBMET00881 0.071 0.069 DBMET00879 | DBMET00531 | |
| 0.026 | 0.062 | 0.071 | Dopamine D5 agonist | 0.071 0.008 DBMET00531 0.047 0.02 DBMET00873 0.059 0.012 DBMET00834 0.048 0.019 DBMET00872 0.048 0.019 DBMET00874 | DBMET00531 | |
| 0.013 | 0.049 | 0.039 | Glutamate (mGluR1a) agonist | 0.039 0.006 DBMET00531 0.027 0.01 DBMET00834 | DBMET00531 | |
| 0.107 | 0.146 | 0.212 | Arachidonic acid antagonist | 0.212 0.023 DBMET00531 0.131 0.111 DBMET00873 | DBMET00531 | |
| 0.13 | 0.171 | 0.216 | Neurotrophic factor enhancer | 0.216 0.062 DBMET00531 0.151 0.137 DBMET00315 0.183 0.094 DBMET00873 0.147 0.142 DBMET00834 0.204 0.072 DBMET00872 0.187 0.09 DBMET00881 0.204 0.072 DBMET00874 0.187 0.09 DBMET00879 | DBMET00531 | |
| 0.08 | 0.122 | 0.11 | Beta amyloid protein antagonist | 0.11 0.078 DBMET00834 | DBMET00834 | |
| 0.025 | 0.067 | 0.034 | Integrin alpha2 antagonist | 0.034 0.031 DBMET00531 | DBMET00531 | |
| 0.059 | 0.103 | 0.118 | Glycine receptor antagonist | 0.118 0.019 DBMET00531 0.089 0.044 DBMET00881 0.089 0.044 DBMET00879 | DBMET00531 | |
| 0.017 | 0.063 | 0.028 | Acid ceramidase inhibitor | 0.028 0.012 DBMET00531 | DBMET00531 | |
| 0.023 | 0.069 | 0.103 | Estrogen agonist | 0.103 0.017 DBMET00873 0.081 0.023 DBMET00872 0.062 0.029 DBMET00881 0.081 0.023 DBMET00874 0.062 0.029 DBMET00879 | DBMET00873 | |
| 0.019 | 0.066 | 0.034 | Retinoid X alpha receptor agonist | 0.034 0.025 DBMET00531 | DBMET00531 | |
| 0.038 | 0.086 | 0.061 | Dopamine agonist | 0.057 0.055 DBMET00873 0.061 0.051 DBMET00872 0.061 0.051 DBMET00874 | DBMET00874 | |
| 0.031 | 0.08 | 0.054 | Histamine H1 receptor agonist | 0.054 0.013 DBMET00531 0.044 0.029 DBMET00315 | DBMET00531 | |
| 0.016 | 0.068 | 0.035 | Vanilloid 2 agonist | 0.035 0.006 DBMET00531 | DBMET00531 | |
| 0.086 | 0.141 | 0.124 | Nav1.6 sodium channel blocker | 0.124 0.089 DBMET00531 | DBMET00531 | |
| 0.024 | 0.079 | 0.064 | Guanylate cyclase inhibitor | 0.064 0.008 DBMET00531 0.046 0.025 DBMET00844 0.043 0.029 DBMET00845 | DBMET00531 | |
| 0.015 | 0.07 | 0.069 | Sodium/glucose cotransporter inhibitor | 0.044 0.006 DBMET00845 0.069 0.004 DBMET00881 0.069 0.004 DBMET00879 | DBMET00879 | |
| 0.043 | 0.098 | 0.066 | Potassium channel intermediate-conductance Ca-activated blocker | 0.066 0.031 DBMET00531 | DBMET00531 | |
| 0.008 | 0.064 | 0.017 | Alpha 2c adrenoreceptor agonist | 0.017 0.015 DBMET00315 | DBMET00315 | |
| 0.023 | 0.079 | 0.05 | GABA uptake inhibitor | 0.05 0.016 DBMET00531 | DBMET00531 | |
| 0.015 | 0.073 | 0.026 | Glutamate (mGluR1) agonist | 0.026 0.014 DBMET00531 | DBMET00531 | |
| 0.068 | 0.128 | 0.101 | Nitric-oxide synthase inhibitor | 0.101 0.058 DBMET00315 0.1 0.059 DBMET00834 | DBMET00315 | |
| 0.017 | 0.078 | 0.034 | Diamine oxidase inhibitor | 0.034 0.031 DBMET00531 | DBMET00531 | |
| 0.004 | 0.065 | 0.02 | Lysophosphatidic acid receptor 3 agonist | 0.02 0.005 DBMET00531 | DBMET00531 | |
| 0.049 | 0.115 | 0.125 | Ornithine decarboxylase inhibitor | 0.096 0.048 DBMET00531 0.097 0.047 DBMET00315 0.125 0.022 DBMET00834 0.1 0.044 DBMET00872 0.1 0.044 DBMET00874 | DBMET00834 | |
| 0.051 | 0.126 | 0.094 | Carbonic anhydrase VI inhibitor | 0.084 0.052 DBMET00531 0.094 0.043 DBMET00834 | DBMET00834 | |
| 0.007 | 0.081 | 0.069 | Estrogen receptor beta agonist | 0.069 0.016 DBMET00873 0.031 0.023 DBMET00872 0.031 0.023 DBMET00874 | DBMET00873 | |
| 0.042 | 0.118 | 0.074 | Protease 3C (Human rhinovirus) inhibitor | 0.074 0.033 DBMET00531 | DBMET00531 | |
| 0.03 | 0.106 | 0.111 | Glucose-6-phosphate isomerase inhibitor | 0.111 0.004 DBMET00531 0.05 0.029 DBMET00845 | DBMET00531 | |
| 0.104 | 0.181 | 0.225 | Interferon gamma antagonist | 0.171 0.056 DBMET00531 0.128 0.114 DBMET00873 0.125 0.122 DBMET00872 0.172 0.056 DBMET00845 0.225 0.033 DBMET00881 0.125 0.122 DBMET00874 0.225 0.033 DBMET00879 | DBMET00879 | |
| 0.05 | 0.129 | 0.101 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.101 0.013 DBMET00531 | DBMET00531 | |
| 0.118 | 0.199 | 0.187 | Ca2+-transporting ATPase inhibitor | 0.187 0.005 DBMET00531 | DBMET00531 | |
| 0.018 | 0.099 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.028 0.014 DBMET00531 | DBMET00531 | |
| 0.057 | 0.14 | 0.2 | Creatine kinase inhibitor | 0.2 0.01 DBMET00531 0.113 0.047 DBMET00873 0.087 0.077 DBMET00834 0.096 0.064 DBMET00872 0.096 0.064 DBMET00874 | DBMET00531 | |
| 0.065 | 0.149 | 0.124 | Cholesterol synthesis inhibitor | 0.124 0.061 DBMET00531 | DBMET00531 | |
| 0.005 | 0.092 | 0.018 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.018 0.005 DBMET00531 | DBMET00531 | |
| 0.061 | 0.15 | 0.119 | Lanosterol 14 alpha demethylase inhibitor | 0.119 0.032 DBMET00531 0.085 0.081 DBMET00834 | DBMET00531 | |
| 0.042 | 0.131 | 0.067 | Interferon inducer | 0.067 0.039 DBMET00531 | DBMET00531 | |
| 0.047 | 0.136 | 0.103 | Exportin-1 inhibitor | 0.103 0.008 DBMET00531 | DBMET00531 | |
| 0.01 | 0.1 | 0.021 | Protease (Human cytomegalovirus) inhibitor | 0.021 0.017 DBMET00531 | DBMET00531 | |
| 0.042 | 0.132 | 0.055 | Leukotriene C antagonist | 0.055 0.045 DBMET00531 | DBMET00531 | |
| 0.102 | 0.193 | 0.198 | Interleukin 6 antagonist | 0.198 0.042 DBMET00881 0.198 0.042 DBMET00879 | DBMET00879 | |
| 0.057 | 0.149 | 0.117 | ATPase (Vacuolar H+) inhibitor | 0.082 0.074 DBMET00872 0.1 0.04 DBMET00845 0.117 0.022 DBMET00881 0.082 0.074 DBMET00874 0.117 0.022 DBMET00879 | DBMET00879 | |
| 0.042 | 0.134 | 0.104 | Glutamate (mGluR7) antagonist | 0.104 0.009 DBMET00531 | DBMET00531 | |
| 0.018 | 0.111 | 0.062 | Carbonic anhydrase VB inhibitor | 0.062 0.033 DBMET00531 | DBMET00531 | |
| 0.062 | 0.156 | 0.205 | GABA C receptor rho-1 antagonist | 0.205 0.007 DBMET00531 0.098 0.066 DBMET00315 0.141 0.026 DBMET00834 0.09 0.078 DBMET00872 0.09 0.078 DBMET00874 | DBMET00531 | |
| 0.046 | 0.141 | 0.063 | Beta 2 adrenoreceptor agonist | 0.063 0.036 DBMET00872 0.063 0.036 DBMET00874 | DBMET00874 | |
| 0.035 | 0.13 | 0.07 | Carbonic anhydrase XIII inhibitor | 0.07 0.058 DBMET00531 0.068 0.061 DBMET00834 | DBMET00531 | |
| 0.022 | 0.117 | 0.054 | Nerve growth factor antagonist | 0.054 0.014 DBMET00531 | DBMET00531 | |
| 0.107 | 0.203 | 0.189 | 3C-like protease (Human coronavirus) inhibitor | 0.189 0.059 DBMET00531 0.14 0.119 DBMET00834 | DBMET00531 | |
| 0.099 | 0.195 | 0.375 | Hepatoprotectant | 0.145 0.115 DBMET00873 0.149 0.11 DBMET00872 0.339 0.021 DBMET00845 0.375 0.016 DBMET00881 0.149 0.11 DBMET00874 0.375 0.016 DBMET00879 | DBMET00879 | |
| 0.011 | 0.106 | 0.023 | Neuraminidase (Influenza B) inhibitor | 0.023 0.011 DBMET00531 | DBMET00531 | |
| 0.02 | 0.117 | 0.063 | Histamine H2 receptor agonist | 0.063 0.013 DBMET00531 | DBMET00531 | |
| 0.012 | 0.11 | 0.032 | Lysophosphatidic acid receptor 1 agonist | 0.032 0.009 DBMET00531 | DBMET00531 | |
| 0.057 | 0.156 | 0.229 | NADH dehydrogenase inhibitor | 0.229 0.009 DBMET00531 0.095 0.05 DBMET00845 0.098 0.046 DBMET00881 0.098 0.046 DBMET00879 | DBMET00531 | |
| 0.113 | 0.212 | 0.373 | Tumour necrosis factor alpha release inhibitor | 0.234 0.083 DBMET00845 0.373 0.032 DBMET00881 0.373 0.032 DBMET00879 | DBMET00879 | |
| 0.107 | 0.206 | 0.431 | Immunostimulant | 0.157 0.149 DBMET00834 0.41 0.047 DBMET00845 0.431 0.041 DBMET00881 0.431 0.041 DBMET00879 | DBMET00879 | |
| 0.139 | 0.239 | 0.317 | Hypoxia-inducible factor 1 alpha inhibitor | 0.21 0.14 DBMET00873 0.19 0.165 DBMET00872 0.317 0.058 DBMET00845 0.234 0.115 DBMET00881 0.19 0.165 DBMET00874 0.234 0.115 DBMET00879 | DBMET00845 | |
| 0.025 | 0.125 | 0.042 | Vanilloid 3 antagonist | 0.042 0.018 DBMET00531 | DBMET00531 | |
| 0.156 | 0.257 | 0.276 | Caspase 3 stimulant | 0.234 0.127 DBMET00873 0.227 0.134 DBMET00872 0.2 0.169 DBMET00845 0.276 0.092 DBMET00881 0.227 0.134 DBMET00874 0.276 0.092 DBMET00879 | DBMET00879 | |
| 0.074 | 0.178 | 0.094 | Factor V inhibitor | 0.093 0.086 DBMET00315 0.094 0.085 DBMET00834 | DBMET00834 | |
| 0.046 | 0.15 | 0.114 | Glycine receptor agonist | 0.114 0.014 DBMET00531 0.092 0.026 DBMET00834 | DBMET00531 | |
| 0.025 | 0.128 | 0.046 | Prolyl endopeptidase inhibitor | 0.046 0.043 DBMET00531 | DBMET00531 | |
| 0.044 | 0.148 | 0.079 | Potassium channel (Tandem pore domain) blocker | 0.079 0.037 DBMET00531 | DBMET00531 | |
| 0.011 | 0.115 | 0.023 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.023 0.01 DBMET00531 | DBMET00531 | |
| 0.057 | 0.163 | 0.187 | 5 Hydroxytryptamine 3A agonist | 0.187 0.019 DBMET00531 0.121 0.055 DBMET00834 | DBMET00531 | |
| 0.082 | 0.188 | 0.175 | Diuretic | 0.175 0.057 DBMET00881 0.175 0.057 DBMET00879 | DBMET00879 | |
| 0.018 | 0.126 | 0.035 | Retinoid X alpha receptor antagonist | 0.035 0.023 DBMET00531 | DBMET00531 | |
| 0.055 | 0.162 | 0.497 | GABA C receptor agonist | 0.497 0.004 DBMET00531 0.204 0.02 DBMET00834 | DBMET00531 | |
| 0.078 | 0.187 | 0.193 | Protein kinase stimulant | 0.128 0.085 DBMET00531 0.138 0.077 DBMET00834 0.133 0.081 DBMET00872 0.117 0.096 DBMET00845 0.193 0.044 DBMET00881 0.133 0.081 DBMET00874 0.193 0.044 DBMET00879 | DBMET00879 | |
| 0.069 | 0.179 | 0.525 | Aldehyde dehydrogenase inhibitor | 0.525 0.004 DBMET00531 0.103 0.093 DBMET00872 0.103 0.093 DBMET00874 | DBMET00531 | |
| 0.061 | 0.171 | 0.162 | Alkylator | 0.119 0.069 DBMET00845 0.162 0.041 DBMET00881 0.162 0.041 DBMET00879 | DBMET00879 | |
| 0.091 | 0.202 | 0.336 | Nitric oxide antagonist | 0.142 0.103 DBMET00873 0.137 0.109 DBMET00872 0.289 0.043 DBMET00845 0.336 0.034 DBMET00881 0.137 0.109 DBMET00874 0.336 0.034 DBMET00879 | DBMET00879 | |
| 0.066 | 0.179 | 0.257 | Adenylate kinase inhibitor | 0.257 0.009 DBMET00531 | DBMET00531 | |
| 0.03 | 0.143 | 0.066 | Carbonic anhydrase VA inhibitor | 0.066 0.051 DBMET00531 | DBMET00531 | |
| 0.004 | 0.118 | 0.038 | Estrogen receptor alpha agonist | 0.038 0.021 DBMET00873 | DBMET00873 | |
| 0.056 | 0.17 | 0.141 | Anabolic | 0.141 0.023 DBMET00531 | DBMET00531 | |
| 0.07 | 0.186 | 0.129 | Acetylcholine release stimulant | 0.129 0.036 DBMET00531 | DBMET00531 | |
| 0.02 | 0.136 | 0.039 | Retinoid X receptor antagonist | 0.039 0.025 DBMET00531 | DBMET00531 | |
| 0.027 | 0.144 | 0.052 | Potassium channel (ATP-sensitive) activator | 0.052 0.027 DBMET00531 | DBMET00531 | |
| 0.064 | 0.181 | 0.124 | Glutamate release inhibitor | 0.124 0.019 DBMET00531 | DBMET00531 | |
| 0.028 | 0.147 | 0.055 | Potassium channel (Inward rectifier) activator | 0.055 0.027 DBMET00531 | DBMET00531 | |
| 0.048 | 0.167 | 0.126 | Falcipain 3 inhibitor | 0.126 0.05 DBMET00531 | DBMET00531 | |
| 0.053 | 0.173 | 0.104 | Chelator | 0.104 0.072 DBMET00873 0.102 0.074 DBMET00872 0.102 0.074 DBMET00874 | DBMET00873 | |
| 0.063 | 0.183 | 0.127 | Microtubule formation inhibitor | 0.127 0.053 DBMET00531 | DBMET00531 | |
| 0.015 | 0.136 | 0.055 | Geranyltranstransferase inhibitor | 0.055 0.018 DBMET00531 | DBMET00531 | |
| 0.009 | 0.131 | 0.021 | Antibiotic Anthracycline-like | 0.021 0.01 DBMET00531 | DBMET00531 | |
| 0.039 | 0.163 | 0.229 | Monophenol monooxygenase inhibitor | 0.099 0.077 DBMET00873 0.099 0.077 DBMET00834 0.114 0.066 DBMET00872 0.126 0.058 DBMET00845 0.229 0.027 DBMET00881 0.114 0.066 DBMET00874 0.229 0.027 DBMET00879 | DBMET00879 | |
| 0.064 | 0.189 | 0.256 | Lipid peroxidase inhibitor | 0.155 0.065 DBMET00873 0.127 0.087 DBMET00872 0.166 0.058 DBMET00845 0.256 0.026 DBMET00881 0.127 0.087 DBMET00874 0.256 0.026 DBMET00879 | DBMET00879 | |
| 0.006 | 0.132 | 0.017 | Purinergic P2Y1 agonist | 0.017 0.008 DBMET00531 | DBMET00531 | |
| 0.01 | 0.136 | 0.022 | Retinoid X beta receptor antagonist | 0.022 0.011 DBMET00531 | DBMET00531 | |
| 0.005 | 0.134 | 0.045 | Arginase inhibitor | 0.045 0.018 DBMET00531 | DBMET00531 | |
| 0.039 | 0.168 | 0.076 | Macrophage migration inhibitory factor inhibitor | 0.076 0.057 DBMET00873 0.071 0.064 DBMET00872 0.071 0.064 DBMET00874 | DBMET00873 | |
| 0.026 | 0.156 | 0.059 | Dopamine beta hydroxylase inhibitor | 0.059 0.017 DBMET00531 | DBMET00531 | |
| 0.024 | 0.155 | 0.06 | Carbonic anhydrase V inhibitor | 0.06 0.054 DBMET00531 | DBMET00531 | |
| 0.077 | 0.208 | 0.125 | Sphingosine 1-phosphate receptor 4 antagonist | 0.125 0.064 DBMET00531 | DBMET00531 | |
| 0.004 | 0.139 | 0.047 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.047 0.01 DBMET00531 | DBMET00531 | |
| 0.048 | 0.183 | 0.101 | Vanilloid 4 agonist | 0.101 0.016 DBMET00531 | DBMET00531 | |
| 0.084 | 0.221 | 0.129 | Vanilloid 1 agonist | 0.129 0.068 DBMET00531 | DBMET00531 | |
| 0.024 | 0.16 | 0.144 | Aconitate hydratase inhibitor | 0.144 0.004 DBMET00531 | DBMET00531 | |
| 0.062 | 0.199 | 0.096 | Phosphodiesterase 6D inhibitor | 0.089 0.077 DBMET00531 0.096 0.06 DBMET00881 0.096 0.06 DBMET00879 | DBMET00879 | |
| 0.055 | 0.193 | 0.132 | Granulocyte macrophage colony stimulating factor agonist | 0.132 0.01 DBMET00531 | DBMET00531 | |
| 0.014 | 0.153 | 0.052 | Oxytocin agonist | 0.052 0.022 DBMET00531 | DBMET00531 | |
| 0.031 | 0.17 | 0.11 | Purinergic P2X1 antagonist | 0.11 0.014 DBMET00531 | DBMET00531 | |
| 0.031 | 0.171 | 0.069 | 5 Hydroxytryptamine 3 agonist | 0.069 0.037 DBMET00531 | DBMET00531 | |
| 0.006 | 0.146 | 0.024 | Telomerase stimulant | 0.024 0.005 DBMET00531 | DBMET00531 | |
| 0.116 | 0.257 | 0.342 | Superoxide dismutase inhibitor | 0.342 0.038 DBMET00531 0.296 0.052 DBMET00834 0.175 0.149 DBMET00872 0.175 0.149 DBMET00874 | DBMET00531 | |
| 0.022 | 0.165 | 0.205 | Phosphofructokinase-1 inhibitor | 0.205 0.011 DBMET00531 0.081 0.04 DBMET00845 | DBMET00531 | |
| 0.016 | 0.16 | 0.033 | Hedgehog signaling activator | 0.033 0.009 DBMET00531 | DBMET00531 | |
| 0.022 | 0.166 | 0.196 | Carbamoyl phosphate synthetase inhibitor | 0.196 0.008 DBMET00531 | DBMET00531 | |
| 0.038 | 0.182 | 0.069 | Ryanodine receptor antagonist | 0.069 0.018 DBMET00531 | DBMET00531 | |
| 0.04 | 0.185 | 0.06 | Histone deacetylase SIRT3 inhibitor | 0.06 0.048 DBMET00531 | DBMET00531 | |
| 0.022 | 0.168 | 0.077 | Alpha-mannosidase inhibitor | 0.077 0.012 DBMET00531 0.06 0.027 DBMET00845 0.056 0.033 DBMET00881 0.056 0.033 DBMET00879 | DBMET00531 | |
| 0.139 | 0.285 | 0.244 | 15-Lipoxygenase inhibitor | 0.244 0.169 DBMET00873 0.237 0.175 DBMET00872 0.237 0.175 DBMET00874 | DBMET00873 | |
| 0.019 | 0.166 | 0.065 | Antibiotic Aminoglycoside-like | 0.058 0.009 DBMET00845 0.065 0.007 DBMET00881 0.065 0.007 DBMET00879 | DBMET00879 | |
| 0.009 | 0.156 | 0.024 | Prostaglandin F2 alpha agonist | 0.024 0.014 DBMET00531 | DBMET00531 | |
| 0.01 | 0.159 | 0.022 | Methylmalonyl-CoA mutase inhibitor | 0.022 0.006 DBMET00531 | DBMET00531 | |
| 0.124 | 0.275 | 0.268 | RNA-directed DNA polymerase inhibitor | 0.268 0.041 DBMET00531 | DBMET00531 | |
| 0.004 | 0.158 | 0.019 | Thromboxane A2 agonist | 0.019 0.007 DBMET00531 | DBMET00531 | |
| 0.046 | 0.203 | 0.208 | Cystathionine beta-synthase inhibitor | 0.208 0.023 DBMET00531 0.091 0.089 DBMET00873 | DBMET00531 | |
| 0.026 | 0.183 | 0.043 | Beta adrenoreceptor agonist | 0.043 0.042 DBMET00872 0.043 0.042 DBMET00874 | DBMET00874 | |
| 0.022 | 0.18 | 0.062 | Kainate receptor agonist | 0.062 0.006 DBMET00531 | DBMET00531 | |
| 0.029 | 0.187 | 0.047 | Heme oxygenase inhibitor | 0.047 0.018 DBMET00531 | DBMET00531 | |
| 0.036 | 0.194 | 0.176 | Glutamate dehydrogenase inhibitor | 0.176 0.012 DBMET00531 0.066 0.064 DBMET00834 | DBMET00531 | |
| 0.121 | 0.279 | 0.346 | Cholesterol antagonist | 0.303 0.089 DBMET00531 0.238 0.134 DBMET00845 0.346 0.066 DBMET00881 0.346 0.066 DBMET00879 | DBMET00879 | |
| 0.013 | 0.172 | 0.038 | Toll-Like receptor 2 agonist | 0.038 0.031 DBMET00531 | DBMET00531 | |
| 0.025 | 0.185 | 0.141 | Phenylalanine 4-hydroxylase inhibitor | 0.141 0.013 DBMET00531 0.06 0.057 DBMET00834 | DBMET00531 | |
| 0.026 | 0.188 | 0.056 | Epithelial sodium channel blocker | 0.056 0.035 DBMET00531 | DBMET00531 | |
| 0.034 | 0.195 | 0.1 | GABA aminotransferase inhibitor | 0.1 0.027 DBMET00531 0.071 0.059 DBMET00834 | DBMET00531 | |
| 0.017 | 0.18 | 0.033 | Protein kinase (CK2) beta inhibitor | 0.033 0.024 DBMET00531 | DBMET00531 | |
| 0.009 | 0.171 | 0.086 | Fumarate hydratase inhibitor | 0.086 0.006 DBMET00531 | DBMET00531 | |
| 0.06 | 0.224 | 0.14 | Toll-Like receptor 2 antagonist | 0.14 0.059 DBMET00531 0.122 0.076 DBMET00834 0.114 0.084 DBMET00872 0.114 0.084 DBMET00874 | DBMET00531 | |
| 0.04 | 0.205 | 0.107 | Glutamate (mGluR6) antagonist | 0.107 0.008 DBMET00531 | DBMET00531 | |
| 0.022 | 0.187 | 0.142 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.142 0.009 DBMET00531 | DBMET00531 | |
| 0.025 | 0.191 | 0.038 | CF transmembrane conductance regulator antagonist | 0.038 0.034 DBMET00531 | DBMET00531 | |
| 0.006 | 0.172 | 0.033 | Nicotinic alpha4beta2 receptor agonist | 0.033 0.014 DBMET00531 | DBMET00531 | |
| 0.022 | 0.189 | 0.046 | GABA B receptor antagonist | 0.046 0.024 DBMET00834 | DBMET00834 | |
| 0.032 | 0.199 | 0.059 | Aryl hydrocarbon receptor antagonist | 0.059 0.056 DBMET00531 | DBMET00531 | |
| 0.003 | 0.17 | 0.033 | Carbonic anhydrase X inhibitor | 0.033 0.004 DBMET00531 | DBMET00531 | |
| 0.003 | 0.17 | 0.033 | Carbonic anhydrase VIII inhibitor | 0.033 0.004 DBMET00531 | DBMET00531 | |
| 0.042 | 0.212 | 0.076 | Caspase 7 inhibitor | 0.076 0.071 DBMET00531 | DBMET00531 | |
| 0.029 | 0.2 | 0.131 | Aminopeptidase I inhibitor | 0.131 0.016 DBMET00531 | DBMET00531 | |
| 0.022 | 0.193 | 0.051 | Cytokine production stimulant | 0.051 0.027 DBMET00531 | DBMET00531 | |
| 0.05 | 0.223 | 0.132 | Mucolytic | 0.132 0.045 DBMET00531 | DBMET00531 | |
| 0.053 | 0.227 | 0.619 | Alpha-N-acetylglucosaminidase inhibitor | 0.619 0.004 DBMET00531 0.123 0.074 DBMET00845 | DBMET00531 | |
| 0.024 | 0.199 | 0.263 | Porphobilinogen synthase inhibitor | 0.263 0.007 DBMET00531 | DBMET00531 | |
| 0.023 | 0.198 | 0.07 | Sphingosine 1-phosphate receptor 4 agonist | 0.07 0.044 DBMET00531 | DBMET00531 | |
| 0.162 | 0.338 | 0.695 | Cyclophilin D inhibitor | 0.237 0.227 DBMET00834 0.489 0.054 DBMET00845 0.695 0.015 DBMET00881 0.695 0.015 DBMET00879 | DBMET00879 | |
| 0.015 | 0.191 | 0.051 | Membrane dipeptidase inhibitor | 0.051 0.015 DBMET00531 | DBMET00531 | |
| 0.122 | 0.299 | 0.353 | Peptidyltransferase inhibitor | 0.238 0.06 DBMET00315 0.25 0.05 DBMET00834 0.252 0.05 DBMET00872 0.333 0.015 DBMET00845 0.353 0.012 DBMET00881 0.252 0.05 DBMET00874 0.353 0.012 DBMET00879 | DBMET00879 | |
| 0.143 | 0.321 | 0.355 | Calcium channel activator | 0.355 0.046 DBMET00531 0.25 0.147 DBMET00315 0.218 0.188 DBMET00872 0.218 0.188 DBMET00874 | DBMET00531 | |
| 0.014 | 0.193 | 0.066 | Mannosidase inhibitor | 0.066 0.014 DBMET00531 0.051 0.024 DBMET00845 0.043 0.034 DBMET00881 0.043 0.034 DBMET00879 | DBMET00531 | |
| 0.071 | 0.251 | 0.199 | Mannose-6-phosphate isomerase inhibitor | 0.199 0.031 DBMET00531 | DBMET00531 | |
| 0.01 | 0.191 | 0.029 | ATP citrate lysase inhibitor | 0.029 0.026 DBMET00531 | DBMET00531 | |
| 0.045 | 0.226 | 0.274 | Triose-phosphate isomerase inhibitor | 0.274 0.005 DBMET00531 0.09 0.06 DBMET00845 | DBMET00531 | |
| 0.009 | 0.192 | 0.037 | Protein 30S ribosomal subunit inhibitor | 0.025 0.016 DBMET00845 0.037 0.011 DBMET00881 0.037 0.011 DBMET00879 | DBMET00879 | |
| 0.019 | 0.202 | 0.044 | Thymidine kinase inhibitor | 0.044 0.024 DBMET00531 | DBMET00531 | |
| 0.007 | 0.192 | 0.037 | Phosphoglycerate kinase inhibitor | 0.037 0.022 DBMET00531 | DBMET00531 | |
| 0.056 | 0.241 | 0.095 | CC chemokine 5 receptor agonist | 0.095 0.028 DBMET00531 | DBMET00531 | |
| 0.036 | 0.222 | 0.064 | Immunoglobulin Fc receptor antagonist | 0.064 0.017 DBMET00531 | DBMET00531 | |
| 0.082 | 0.269 | 0.47 | Free radical scavenger | 0.227 0.079 DBMET00873 0.225 0.08 DBMET00872 0.341 0.041 DBMET00845 0.47 0.019 DBMET00881 0.225 0.08 DBMET00874 0.47 0.019 DBMET00879 | DBMET00879 | |
| 0.016 | 0.204 | 0.094 | Acetylcholine M5 receptor agonist | 0.094 0.023 DBMET00531 | DBMET00531 | |
| 0.026 | 0.214 | 0.099 | Phospholipase D inhibitor | 0.099 0.015 DBMET00531 | DBMET00531 | |
| 0.027 | 0.215 | 0.074 | NMDA receptor agonist | 0.074 0.033 DBMET00531 | DBMET00531 | |
| 0.021 | 0.211 | 0.042 | Purinergic P2X4 antagonist | 0.042 0.041 DBMET00531 | DBMET00531 | |
| 0.047 | 0.239 | 0.095 | Multidrug resistance-associated protein 1 inhibitor | 0.093 0.091 DBMET00845 0.095 0.087 DBMET00881 0.095 0.087 DBMET00879 | DBMET00879 | |
| 0.083 | 0.275 | 0.174 | CF transmembrane conductance regulator agonist | 0.174 0.043 DBMET00531 | DBMET00531 | |
| 0.016 | 0.208 | 0.046 | Neuraminidase (Influenza A) inhibitor | 0.046 0.031 DBMET00881 0.046 0.031 DBMET00879 | DBMET00879 | |
| 0.036 | 0.23 | 0.166 | Expectorant | 0.103 0.065 DBMET00531 0.108 0.06 DBMET00845 0.166 0.029 DBMET00881 0.166 0.029 DBMET00879 | DBMET00879 | |
| 0.034 | 0.229 | 0.171 | Aminopeptidase B inhibitor | 0.171 0.03 DBMET00531 0.092 0.071 DBMET00834 | DBMET00531 | |
| 0.006 | 0.201 | 0.024 | Isoleucine-tRNA ligase inhibitor | 0.024 0.013 DBMET00531 | DBMET00531 | |
| 0.051 | 0.247 | 0.108 | D-Ala-D-Ala ligase inhibitor | 0.108 0.021 DBMET00531 | DBMET00531 | |
| 0.037 | 0.233 | 0.096 | Keratolytic | 0.096 0.033 DBMET00531 | DBMET00531 | |
| 0.041 | 0.238 | 0.078 | Glutathione S-transferase inhibitor | 0.078 0.065 DBMET00531 | DBMET00531 | |
| 0.019 | 0.216 | 0.034 | Adenosine uptake inhibitor | 0.034 0.026 DBMET00531 | DBMET00531 | |
| 0.018 | 0.215 | 0.067 | Glutamate (mGluR8) agonist | 0.067 0.005 DBMET00531 | DBMET00531 | |
| 0.045 | 0.243 | 0.089 | Bromodomain-containing protein 2 inhibitor | 0.089 0.057 DBMET00531 | DBMET00531 | |
| 0.043 | 0.241 | 0.091 | Bile acid receptor antagonist | 0.091 0.072 DBMET00531 | DBMET00531 | |
| 0.003 | 0.202 | 0.016 | Cyclin T1 inhibitor | 0.016 0.015 DBMET00531 | DBMET00531 | |
| 0.039 | 0.241 | 0.309 | UDP-glucose 4-epimerase inhibitor | 0.309 0.01 DBMET00531 0.107 0.054 DBMET00845 | DBMET00531 | |
| 0.006 | 0.209 | 0.139 | 5-Alpha-reductase inhibitor | 0.139 0.007 DBMET00531 | DBMET00531 | |
| 0.023 | 0.226 | 0.165 | Glutamate decarboxylase inhibitor | 0.165 0.011 DBMET00531 0.072 0.053 DBMET00834 | DBMET00531 | |
| 0.01 | 0.213 | 0.101 | Ornithine carbamoyltransferase inhibitor | 0.101 0.016 DBMET00531 | DBMET00531 | |
| 0.015 | 0.219 | 0.143 | Antineoplastic antibiotic | 0.117 0.039 DBMET00845 0.143 0.032 DBMET00881 0.143 0.032 DBMET00879 | DBMET00879 | |
| 0.031 | 0.236 | 0.09 | Adrenaline agonist | 0.09 0.045 DBMET00872 0.09 0.045 DBMET00874 | DBMET00874 | |
| 0.021 | 0.227 | 0.076 | Nicotinic alpha4beta2 receptor antagonist | 0.076 0.054 DBMET00531 | DBMET00531 | |
| 0.038 | 0.249 | 0.378 | Ferrochelatase inhibitor | 0.378 0.004 DBMET00531 | DBMET00531 | |
| 0.052 | 0.264 | 0.166 | DOPA decarboxylase inhibitor | 0.166 0.015 DBMET00531 | DBMET00531 | |
| 0.016 | 0.229 | 0.19 | Biliverdin reductase inhibitor | 0.19 0.006 DBMET00531 | DBMET00531 | |
| 0.009 | 0.221 | 0.021 | Factor XIII inhibitor | 0.021 0.014 DBMET00531 | DBMET00531 | |
| 0.009 | 0.224 | 0.044 | Purinergic P2Y15 antagonist | 0.044 0.005 DBMET00531 | DBMET00531 | |
| 0.027 | 0.244 | 0.048 | Factor III inhibitor | 0.048 0.041 DBMET00881 0.048 0.041 DBMET00879 | DBMET00879 | |
| 0.014 | 0.231 | 0.915 | Alcohol oxidase inhibitor | 0.915 0.002 DBMET00531 | DBMET00531 | |
| 0.036 | 0.254 | 0.079 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.079 0.065 DBMET00834 | DBMET00834 | |
| 0.041 | 0.259 | 0.068 | Calcium channel P-type blocker | 0.068 0.033 DBMET00531 | DBMET00531 | |
| 0.027 | 0.246 | 0.073 | Pregnane X receptor antagonist | 0.073 0.011 DBMET00531 | DBMET00531 | |
| 0.014 | 0.233 | 0.157 | Argininosuccinate synthase inhibitor | 0.157 0.011 DBMET00531 | DBMET00531 | |
| 0.056 | 0.278 | 0.456 | Peroxidase inhibitor | 0.456 0.014 DBMET00531 | DBMET00531 | |
| 0.014 | 0.238 | 0.08 | NMDA receptor glycine site agonist | 0.08 0.028 DBMET00531 | DBMET00531 | |
| 0.006 | 0.235 | 0.03 | Lysine carboxypeptidase inhibitor | 0.03 0.016 DBMET00531 | DBMET00531 | |
| 0.013 | 0.245 | 0.028 | Glucosylceramidase stimulant | 0.028 0.017 DBMET00531 | DBMET00531 | |
| 0.053 | 0.287 | 0.117 | TRPA1 agonist | 0.117 0.062 DBMET00531 | DBMET00531 | |
| 0.05 | 0.285 | 0.188 | Cyclooxygenase 3 inhibitor | 0.143 0.055 DBMET00531 0.138 0.059 DBMET00845 0.188 0.023 DBMET00881 0.188 0.023 DBMET00879 | DBMET00879 | |
| 0.008 | 0.244 | 0.043 | Dihydropteroate synthase inhibitor | 0.043 0.023 DBMET00531 | DBMET00531 | |
| 0.063 | 0.3 | 0.143 | DNA methyltransferase I inhibitor | 0.143 0.112 DBMET00881 0.143 0.112 DBMET00879 | DBMET00879 | |
| 0.008 | 0.246 | 0.028 | MAP3K8 inhibitor | 0.028 0.024 DBMET00531 | DBMET00531 | |
| 0.027 | 0.265 | 0.074 | Histone deacetylase stimulant | 0.074 0.05 DBMET00881 0.074 0.05 DBMET00879 | DBMET00879 | |
| 0.027 | 0.265 | 0.074 | Histone deacetylase SIRT1 stimulant | 0.074 0.05 DBMET00881 0.074 0.05 DBMET00879 | DBMET00879 | |
| 0.005 | 0.245 | 0.031 | Free fatty acid receptor 1 antagonist | 0.031 0.027 DBMET00531 | DBMET00531 | |
| 0.036 | 0.278 | 0.071 | Transcription factor RelA inhibitor | 0.071 0.028 DBMET00531 | DBMET00531 | |
| 0.018 | 0.261 | 0.067 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.067 0.005 DBMET00531 | DBMET00531 | |
| 0.03 | 0.275 | 0.088 | Urease inhibitor | 0.088 0.081 DBMET00531 | DBMET00531 | |
| 0.001 | 0.248 | 0.017 | Glutamate (mGluR6) agonist | 0.017 0.005 DBMET00531 | DBMET00531 | |
| 0.04 | 0.287 | 0.248 | Amylase inhibitor | 0.16 0.059 DBMET00531 0.11 0.088 DBMET00845 0.248 0.028 DBMET00881 0.248 0.028 DBMET00879 | DBMET00879 | |
| 0.114 | 0.362 | 0.279 | Nitric-oxide synthase stimulant | 0.279 0.018 DBMET00531 | DBMET00531 | |
| 0.005 | 0.254 | 0.013 | Cyclin D2 inhibitor | 0.013 0.01 DBMET00531 | DBMET00531 | |
| 0.041 | 0.29 | 0.069 | MDM2 inhibitor | 0.069 0.041 DBMET00531 | DBMET00531 | |
| 0.01 | 0.262 | 0.041 | Glutamate (mGluR3) antagonist | 0.041 0.02 DBMET00531 | DBMET00531 | |
| 0.056 | 0.308 | 0.151 | Insulin sensitizer | 0.151 0.132 DBMET00531 | DBMET00531 | |
| 0.038 | 0.291 | 0.253 | Xanthine oxidase inhibitor | 0.253 0.012 DBMET00531 0.086 0.079 DBMET00881 0.086 0.079 DBMET00879 | DBMET00531 | |
| 0.094 | 0.348 | 0.136 | CC chemokine 6 receptor antagonist | 0.134 0.058 DBMET00845 0.136 0.05 DBMET00881 0.136 0.05 DBMET00879 | DBMET00879 | |
| 0.021 | 0.276 | 0.068 | Heparanase inhibitor | 0.05 0.045 DBMET00531 0.058 0.026 DBMET00845 0.068 0.013 DBMET00881 0.068 0.013 DBMET00879 | DBMET00879 | |
| 0.044 | 0.301 | 0.156 | Cathepsin H inhibitor | 0.156 0.042 DBMET00531 | DBMET00531 | |
| 0.059 | 0.317 | 0.111 | Transcription factor STAT6 inhibitor | 0.111 0.077 DBMET00531 | DBMET00531 | |
| 0.04 | 0.3 | 0.09 | MAP kinase kinase 7 inhibitor | 0.09 0.024 DBMET00531 | DBMET00531 | |
| 0.012 | 0.272 | 0.03 | Complement factor 1s inhibitor | 0.03 0.008 DBMET00531 | DBMET00531 | |
| 0.021 | 0.284 | 0.07 | Sirtuin 1 inhibitor | 0.07 0.045 DBMET00834 | DBMET00834 | |
| 0.037 | 0.303 | 0.248 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.248 0.01 DBMET00531 | DBMET00531 | |
| 0.013 | 0.28 | 0.063 | Lysophosphatidic acid 3 receptor antagonist | 0.063 0.019 DBMET00531 | DBMET00531 | |
| 0.009 | 0.279 | 0.029 | Calcitonin receptor agonist | 0.029 0.028 DBMET00531 | DBMET00531 | |
| 0.036 | 0.309 | 0.094 | GABA B receptor agonist | 0.094 0.022 DBMET00531 | DBMET00531 | |
| 0.111 | 0.386 | 0.367 | Apoptosis antagonist | 0.286 0.095 DBMET00845 0.367 0.049 DBMET00881 0.367 0.049 DBMET00879 | DBMET00879 | |
| 0.004 | 0.28 | 0.043 | Uridine phosphorylase inhibitor | 0.043 0.01 DBMET00531 | DBMET00531 | |
| 0.059 | 0.338 | 0.151 | DNA methylase inhibitor | 0.151 0.117 DBMET00881 0.151 0.117 DBMET00879 | DBMET00879 | |
| 0.032 | 0.312 | 0.139 | HIV-1 integrase (Overall Integration) inhibitor | 0.139 0.03 DBMET00531 | DBMET00531 | |
| 0.017 | 0.297 | 0.093 | Nitric oxide donor | 0.093 0.012 DBMET00845 | DBMET00845 | |
| 0.013 | 0.293 | 0.037 | Tryptophan 5 hydroxylase inhibitor | 0.037 0.022 DBMET00531 | DBMET00531 | |
| 0.004 | 0.285 | 0.039 | Nicotinic alpha3beta4 receptor agonist | 0.039 0.011 DBMET00531 | DBMET00531 | |
| 0.008 | 0.29 | 0.062 | Alpha 1d adrenoreceptor agonist | 0.062 0.01 DBMET00531 | DBMET00531 | |
| 0.012 | 0.294 | 0.039 | Glutamate (mGluR3) agonist | 0.039 0.01 DBMET00531 | DBMET00531 | |
| 0.086 | 0.37 | 0.167 | Neurotensin receptor agonist | 0.167 0.067 DBMET00531 0.139 0.132 DBMET00834 | DBMET00531 | |
| 0.016 | 0.302 | 0.16 | Histidine decarboxylase inhibitor | 0.16 0.018 DBMET00531 | DBMET00531 | |
| 0.014 | 0.301 | 0.35 | Catalase inhibitor | 0.35 0.005 DBMET00531 | DBMET00531 | |
| 0.019 | 0.307 | 0.044 | Glutamate (mGluR group III) antagonist | 0.044 0.03 DBMET00531 | DBMET00531 | |
| 0.006 | 0.299 | 0.034 | Nicotinic acid receptor 2 antagonist | 0.034 0.009 DBMET00531 | DBMET00531 | |
| 0.011 | 0.306 | 0.054 | Adenosine deaminase inhibitor | 0.054 0.026 DBMET00531 | DBMET00531 | |
| 0.002 | 0.297 | 0.016 | Carbonic anhydrase XI inhibitor | 0.016 0.005 DBMET00531 | DBMET00531 | |
| 0.045 | 0.341 | 0.153 | Toll-Like receptor 3 antagonist | 0.153 0.014 DBMET00315 0.125 0.026 DBMET00872 0.125 0.026 DBMET00874 | DBMET00315 | |
| 0.1 | 0.398 | 0.571 | Antibacterial | 0.445 0.059 DBMET00845 0.571 0.024 DBMET00881 0.571 0.024 DBMET00879 | DBMET00879 | |
| 0.045 | 0.345 | 0.145 | I kappa B kinase epsilon inhibitor | 0.145 0.125 DBMET00531 | DBMET00531 | |
| 0.044 | 0.35 | 0.174 | Cell wall synthesis inhibitor | 0.139 0.076 DBMET00531 0.138 0.077 DBMET00845 0.174 0.044 DBMET00881 0.174 0.044 DBMET00879 | DBMET00879 | |
| 0.015 | 0.322 | 0.069 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.069 0.022 DBMET00531 | DBMET00531 | |
| 0.072 | 0.382 | 0.157 | Sphingosine 1-phosphate receptor 5 antagonist | 0.157 0.05 DBMET00531 | DBMET00531 | |
| 0.047 | 0.362 | 0.222 | Hypolipemic | 0.222 0.081 DBMET00881 0.222 0.081 DBMET00879 | DBMET00879 | |
| 0.047 | 0.363 | 0.126 | Histone deacetylase SIRT1 inhibitor | 0.115 0.097 DBMET00315 0.126 0.085 DBMET00834 0.117 0.095 DBMET00872 0.117 0.095 DBMET00874 | DBMET00834 | |
| 0.035 | 0.351 | 0.156 | Electrolyte absorption antagonist | 0.156 0.017 DBMET00531 | DBMET00531 | |
| 0.006 | 0.324 | 0.033 | Epoxide hydrolase 1 inhibitor | 0.033 0.018 DBMET00531 | DBMET00531 | |
| 0.001 | 0.325 | 0.008 | DNA topoisomerase III inhibitor | 0.008 0.004 DBMET00531 | DBMET00531 | |
| 0.017 | 0.343 | 0.046 | Glutamate (mGluR4) antagonist | 0.046 0.025 DBMET00531 | DBMET00531 | |
| 0.007 | 0.343 | 0.028 | Lysophosphatidic acid 2 receptor antagonist | 0.028 0.026 DBMET00531 | DBMET00531 | |
| 0.022 | 0.358 | 0.067 | Corticotropin releasing factor 2 receptor antagonist | 0.067 0.032 DBMET00531 | DBMET00531 | |
| 0.051 | 0.393 | 0.143 | Sphingosine 1-phosphate receptor 2 antagonist | 0.143 0.05 DBMET00531 | DBMET00531 | |
| 0.008 | 0.356 | 0.029 | Thymidine phosphorylase inhibitor | 0.029 0.014 DBMET00531 | DBMET00531 | |
| 0.028 | 0.383 | 0.118 | Beta glucuronidase inhibitor | 0.118 0.047 DBMET00881 0.118 0.047 DBMET00879 | DBMET00879 | |
| 0.004 | 0.365 | 0.034 | Potassium channel small-conductance Ca-activated activator | 0.034 0.019 DBMET00531 | DBMET00531 | |
| 0.012 | 0.374 | 0.081 | Protein 50S ribosomal subunit inhibitor | 0.068 0.025 DBMET00845 0.081 0.019 DBMET00881 0.081 0.019 DBMET00879 | DBMET00879 | |
| 0.026 | 0.39 | 0.089 | Uric acid excretion stimulant | 0.089 0.066 DBMET00881 0.089 0.066 DBMET00879 | DBMET00879 | |
| 0.052 | 0.417 | 0.142 | Pregnane X receptor agonist | 0.142 0.069 DBMET00531 | DBMET00531 | |
| 0.027 | 0.394 | 0.247 | Thrombolytic | 0.132 0.098 DBMET00834 0.18 0.062 DBMET00845 0.247 0.034 DBMET00881 0.247 0.034 DBMET00879 | DBMET00879 | |
| 0.014 | 0.388 | 0.066 | Carbonic anhydrase stimulant | 0.066 0.035 DBMET00531 | DBMET00531 | |
| 0.029 | 0.405 | 0.091 | Thioredoxin inhibitor | 0.091 0.06 DBMET00881 0.091 0.06 DBMET00879 | DBMET00879 | |
| 0.038 | 0.415 | 0.17 | Interleukin antagonist | 0.17 0.103 DBMET00834 | DBMET00834 | |
| 0.012 | 0.398 | 0.048 | AICAR transformylase inhibitor | 0.048 0.024 DBMET00531 | DBMET00531 | |
| 0.013 | 0.402 | 0.058 | Sphingosine kinase 2 inhibitor | 0.058 0.034 DBMET00531 | DBMET00531 | |
| 0.013 | 0.409 | 0.041 | Potassium channel Kv1.1 blocker | 0.041 0.021 DBMET00531 | DBMET00531 | |
| 0.018 | 0.421 | 0.074 | Dihydroorotate oxidase inhibitor | 0.074 0.014 DBMET00531 | DBMET00531 | |
| 0.031 | 0.438 | 0.096 | DNA polymerase I inhibitor | 0.096 0.09 DBMET00881 0.096 0.09 DBMET00879 | DBMET00879 | |
| 0.042 | 0.453 | 0.262 | Interleukin agonist | 0.262 0.07 DBMET00531 | DBMET00531 | |
| 0.021 | 0.432 | 0.097 | Somatostatin 1 agonist | 0.097 0.036 DBMET00834 | DBMET00834 | |
| 0.008 | 0.419 | 0.056 | Neuraminidase inhibitor | 0.056 0.049 DBMET00845 | DBMET00845 | |
| 0.051 | 0.464 | 0.125 | MAP kinase 3 inhibitor | 0.125 0.121 DBMET00531 | DBMET00531 | |
| 0.017 | 0.43 | 0.133 | M18 aspartyl aminopeptidase inhibitor | 0.133 0.061 DBMET00872 0.133 0.061 DBMET00874 | DBMET00874 | |
| 0.002 | 0.424 | 0.019 | Nicotinic acid receptor 1 antagonist | 0.019 0.01 DBMET00531 | DBMET00531 | |
| 0.112 | 0.548 | 0.507 | Calcium channel L-type activator | 0.497 0.029 DBMET00315 0.507 0.025 DBMET00872 0.507 0.025 DBMET00874 | DBMET00874 | |
| 0.057 | 0.495 | 0.524 | Hypoglycemic | 0.38 0.031 DBMET00845 0.524 0.013 DBMET00881 0.524 0.013 DBMET00879 | DBMET00879 | |
| 0.013 | 0.452 | 0.055 | Cyclin D1 inhibitor | 0.055 0.051 DBMET00531 | DBMET00531 | |
| 0.021 | 0.463 | 0.11 | AMP-activated protein kinase stimulant | 0.11 0.058 DBMET00881 0.11 0.058 DBMET00879 | DBMET00879 | |
| 0.01 | 0.458 | 0.068 | Neuraminidase (influenza) inhibitor | 0.068 0.038 DBMET00845 0.061 0.051 DBMET00881 0.061 0.051 DBMET00879 | DBMET00845 | |
| 0.008 | 0.462 | 0.042 | Dihydroorotase inhibitor | 0.042 0.035 DBMET00531 | DBMET00531 | |
| 0.007 | 0.465 | 0.033 | Somatostatin 1 antagonist | 0.033 0.032 DBMET00834 | DBMET00834 | |
| 0.014 | 0.474 | 0.065 | Glucose-6-phosphate translocase inhibitor | 0.051 0.037 DBMET00845 0.065 0.019 DBMET00881 0.065 0.019 DBMET00879 | DBMET00879 | |
| 0.033 | 0.512 | 0.163 | Hemostatic | 0.137 0.086 DBMET00845 0.163 0.054 DBMET00881 0.163 0.054 DBMET00879 | DBMET00879 | |
| 0.061 | 0.56 | 0.215 | Sodium/bile acid cotransporter inhibitor | 0.215 0.168 DBMET00872 0.215 0.168 DBMET00874 | DBMET00874 | |
| 0.036 | 0.537 | 0.142 | Hexokinase inhibitor | 0.142 0.088 DBMET00531 | DBMET00531 | |
| 0.006 | 0.537 | 0.076 | Check point kinase 1 inhibitor | 0.076 0.041 DBMET00844 | DBMET00844 | |
| 0.025 | 0.576 | 0.058 | Lipocortins synthesis agonist | 0.054 0.052 DBMET00845 0.058 0.04 DBMET00881 0.058 0.04 DBMET00879 | DBMET00879 | |
| 0.045 | 0.612 | 0.291 | Immunomodulator | 0.291 0.088 DBMET00881 0.291 0.088 DBMET00879 | DBMET00879 | |
| 0.023 | 0.602 | 0.134 | Toll-Like receptor 4 antagonist | 0.107 0.059 DBMET00845 0.134 0.031 DBMET00881 0.134 0.031 DBMET00879 | DBMET00879 | |
| 0.018 | 0.608 | 0.662 | Angiogenesis stimulant | 0.662 0.005 DBMET00845 0.507 0.011 DBMET00881 0.507 0.011 DBMET00879 | DBMET00845 | |
| 0.01 | 0.624 | 0.073 | Cell adhesion molecule inhibitor | 0.073 0.064 DBMET00881 0.073 0.064 DBMET00879 | DBMET00879 | |
| 0.038 | 0.7 | 0.193 | Growth hormone agonist | 0.193 0.062 DBMET00834 | DBMET00834 | |
| 0.011 | 0.677 | 0.14 | Anticoagulant | 0.14 0.09 DBMET00881 0.14 0.09 DBMET00879 | DBMET00879 | |
| 0.004 | 0.684 | 0.286 | Selectin antagonist | 0.211 0.01 DBMET00845 0.286 0.006 DBMET00881 0.286 0.006 DBMET00879 | DBMET00879 | |
| 0.021 | 0.7 | 0.281 | Platelet adhesion inhibitor | 0.193 0.075 DBMET00845 0.281 0.04 DBMET00881 0.281 0.04 DBMET00879 | DBMET00879 | |
| 0.031 | 0.731 | 0.181 | NOS3 expression enhancer | 0.133 0.093 DBMET00845 0.181 0.05 DBMET00881 0.181 0.05 DBMET00879 | DBMET00879 | |
| 0.025 | 0.727 | 0.099 | Transcription factor NF kappa B stimulant | 0.094 0.046 DBMET00845 0.099 0.04 DBMET00881 0.099 0.04 DBMET00879 | DBMET00879 | |
| 0.038 | 0.75 | 0.143 | Death-associated protein kinase 2 inhibitor | 0.143 0.123 DBMET00834 | DBMET00834 | |
| 0.012 | 0.739 | 0.142 | Cell adhesion inhibitor | 0.142 0.052 DBMET00881 0.142 0.052 DBMET00879 | DBMET00879 | |
| 0.049 | 0.828 | 0.347 | Interleukin 2 agonist | 0.252 0.116 DBMET00834 0.347 0.047 DBMET00845 0.34 0.05 DBMET00881 0.34 0.05 DBMET00879 | DBMET00845 | |
| 0.007 | 0.808 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.022 DBMET00881 0.025 0.022 DBMET00879 | DBMET00879 | |
| 0.009 | 0.853 | 0.139 | Insulin secretagoues | 0.139 0.086 DBMET00881 0.139 0.086 DBMET00879 | DBMET00879 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |